P. Y. Wen and S. Kesari, Malignant Gliomas in Adults, N. Engl. J. Med, vol.359, pp.492-507, 2008.

V. Rigau, S. Zouaoui, H. Mathieu-daudé, A. Darlix, A. Maran et al., French brain tumor database: 5-year histological results on 25 756 cases, Brain Pathol. Zurich Switz, vol.21, pp.633-677, 2011.

R. Stupp, N. Pavlidis, and S. Jelic, ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. Esmo, vol.16, issue.1, pp.64-65, 2005.

A. Giese, R. Bjerkvig, M. E. Berens, and M. Westphal, Cost of migration: invasion of malignant gliomas and implications for treatment, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.21, pp.1624-1660, 2003.

A. Johnston, X. Lun, J. J. Rahn, A. Liacini, L. Wang et al., The p75 neurotrophin receptor is a central regulator of glioma invasion, Plos Biol, vol.5, p.212, 2007.

D. Zagzag, M. Esencay, O. Mendez, H. Yee, I. Smirnova et al., Hypoxia-and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1?/CXCR4 Expression in Glioblastomas: One Plausible Explanation of Scherer's Structures, Am. J. Pathol, vol.173, pp.545-60, 2008.

S. A. Rempel, S. Dudas, S. Ge, and J. A. Gutiérrez, Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.6, pp.102-113, 2000.

S. Wang, J. Hong, C. Hsueh, and C. Chiang, Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model, Lab. Investig. J. Tech. Methods Pathol, vol.92, pp.151-62, 2012.

B. E. Mugabe, F. A. Yaghini, C. Y. Song, C. K. Buharalioglu, C. M. Waters et al.,

, Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation, J. Pharmacol. Exp. Ther, vol.332, pp.116-140, 2010.

Z. Daher, J. Noël, and A. Claing, Endothelin-1 promotes migration of endothelial cells through the activation of ARF6 and the regulation of FAK activity, Cell. Signal, vol.20, pp.2256-65, 2008.

K. Nishikawa, K. Ayukawa, Y. Hara, K. Wada, and S. Aoki, Endothelin/endothelin-B receptor signals regulate ventricle-directed interkinetic nuclear migration of cerebral cortical neural progenitors, Neurochem. Int, vol.58, pp.261-72, 2011.

P. J. Medeiros, B. K. Al-khazraji, N. M. Novielli, L. M. Postovit, A. F. Chambers et al.,

, Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line, Int. J. Cancer J. Int. Cancer, vol.131, pp.276-86, 2012.

D. Lu, Y. Leung, S. Huang, and K. Wong, Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells, J. Cell. Biochem, vol.110, pp.141-50, 2010.

J. Segain, M. Rolli-derkinderen, N. Gervois, R. De-la-blétière, D. Loirand et al., Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes, J. Immunol. Baltim. Md, vol.179, pp.901-910, 1950.

Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint et al., Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.15803-15811, 1998.

T. Sugo, Y. Murakami, Y. Shimomura, M. Harada, M. Abe et al., Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain, Biochem. Biophys. Res. Commun, vol.310, pp.860-868, 2003.

R. S. Ames, H. M. Sarau, J. K. Chambers, R. N. Willette, N. V. Aiyar et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, Nature, vol.401, pp.282-288, 1999.

C. D. Proulx, B. J. Holleran, P. Lavigne, E. Escher, G. Guillemette et al., Biological properties and functional determinants of the urotensin II receptor, Peptides, vol.29, pp.691-700, 2008.

S. A. Douglas, D. Dhanak, and D. G. Johns, From "gills to pills": urotensin-II as a regulator of mammalian cardiorenal function, Trends Pharmacol. Sci, vol.25, pp.76-85, 2004.

B. Ross, K. Mckendy, and A. Giaid, Role of urotensin II in health and disease, Am. J. Physiol. -Regul. Integr. Comp. Physiol, vol.298, pp.1156-1172, 2010.

Y. Zhang, J. Li, Y. Li, and R. Wei, Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta, J. Hypertens, vol.26, pp.1119-1145, 2008.

S. Xu, H. Jiang, B. Wu, J. Yang, and S. Chen, Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway, Tohoku J. Exp. Med, vol.219, pp.283-291, 2009.

P. Grieco, R. Franco, G. Bozzuto, L. Toccacieli, A. Sgambato et al., Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells, J. Cell. Biochem, vol.112, pp.341-53, 2011.

Y. Wu, Z. Song, C. Zhou, S. Xing, P. Zheng et al., Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo, Oncol. Rep, vol.24, pp.1179-84, 2010.

C. Zhou, Y. Wan, X. Chu, Z. Song, S. Xing et al., Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-?B pathway in tumor-bearing nude mice, Oncol. Lett, vol.4, pp.1259-63, 2012.

K. Takahashi, K. Totsune, O. Murakami, and S. Shibahara, Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells, Peptides, vol.22, pp.1175-1184, 2001.

K. Takahashi, K. Totsune, O. Murakami, Z. Arihara, T. Noshiro et al., Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II, Peptides, vol.24, pp.301-307, 2003.

Y. Lin, T. Tsuchihashi, K. Matsumura, M. Fukuhara, Y. Ohya et al., Central cardiovascular action of urotensin II in spontaneously hypertensive rats, Hypertens. Res. Off. J. Jpn. Soc. Hypertens, vol.26, pp.839-884, 2003.

H. Castel, M. Diallo, D. Chatenet, J. Leprince, L. Desrues et al., Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes, J. Neurochem, vol.99, pp.582-95, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01960748

M. Jarry, M. Diallo, C. Lecointre, L. Desrues, T. Tokay et al., The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation, Biochem. J, vol.428, pp.113-137, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00479207

L. Desrues, T. Lefebvre, C. Lecointre, M. Schouft, J. Leprince et al., Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide
URL : https://hal.archives-ouvertes.fr/hal-02294501

K. Tamura, M. Okazaki, M. Tamura, K. Isozumi, H. Tasaki et al., Urotensin IIinduced activation of extracellular signal-regulated kinase in cultured vascular smooth muscle cells: involvement of cell adhesion-mediated integrin signaling, Life Sci, vol.72, pp.1049-60, 2003.

T. Djordjevic, R. S. Belaiba, S. Bonello, J. Pfeilschifter, J. Hess et al., Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells, Arterioscler. Thromb. Vasc. Biol, vol.25, pp.519-544, 2005.

Y. Zhou, P. H. Larsen, C. Hao, and V. W. Yong, CXCR4 is a major chemokine receptor on glioma cells and mediates their survival, J. Biol. Chem, vol.277, pp.49481-49488, 2002.

Y. Chen, M. Zhao, X. Liu, W. Yao, J. Yang et al., Urotensin II receptor in the rat airway smooth muscle and its effect on the rat airway smooth muscle cells proliferation, Chin. Med. Sci. J. Chung-Kuo Hsüeh Ko Hsüeh Tsa Chih Chin. Acad. Med. Sci, vol.16, pp.231-236, 2001.

M. Matsushita, M. Shichiri, N. Fukai, N. Ozawa, T. Yoshimoto et al.,

, Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology, vol.144, pp.1825-1856, 2003.

V. Sauzeau, L. Mellionnec, E. Bertoglio, J. Scalbert, E. Pacaud et al., Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase, Circ. Res, vol.88, pp.1102-1106, 2001.

Q. Liu, S. S. Pong, Z. Zeng, Q. Zhang, A. D. Howard et al., Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14, Biochem. Biophys. Res. Commun, vol.266, pp.174-182, 1999.

B. A. Teicher and S. P. Fricker, CXCL12 (SDF-1)/CXCR4 Pathway in Cancer, Clin. Cancer Res, vol.16, pp.2927-2958, 2010.

P. Mitra, A. De, M. F. Ethier, K. Mimori, K. Kodys et al., Loss of chemokine SDF-1alpha-mediated CXCR4 signalling and receptor internalization in human hepatoma cell line HepG2, Cell. Signal, vol.13, pp.311-320, 2001.

Y. Zhang, Z. Kuang, Y. Mao, R. Wei, S. Bao et al., Osteopontin is involved in urotensin II-induced migration of rat aortic adventitial fibroblasts, Peptides, vol.32, pp.2452-2460, 2011.

K. Yi, M. Yu, L. Wu, and X. Tan, Effects of urotensin II on functional activity of late endothelial progenitor cells, Peptides, vol.33, pp.87-91, 2012.

W. Song, J. Mcdonald, V. Camarda, G. Calo, R. Guerrini et al., Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity, Naunyn. Schmiedebergs Arch. Pharmacol, vol.373, pp.148-57, 2006.

C. D. Proulx, B. J. Holleran, A. A. Boucard, E. Escher, G. Guillemette et al., Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor, Mol. Pharmacol, vol.74, pp.552-61, 2008.

W. Tan, D. Martin, and J. S. Gutkind, The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4, J. Biol. Chem, vol.281, pp.39542-39551, 2006.

T. S. Panetti, J. Nowlen, and D. F. Mosher, Sphingosine-1-Phosphate and Lysophosphatidic Acid Stimulate Endothelial Cell Migration, Arterioscler. Thromb. Vasc. Biol, vol.20, pp.1013-1022, 2000.

D. Bian, C. Mahanivong, J. Yu, S. M. Frisch, Z. K. Pan et al., The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration, Oncogene, vol.25, pp.2234-2278, 2006.

V. Bülow, C. Hayen, W. Hartmann, A. Mueller-klieser, W. Allolio et al., Endothelial capillaries chemotactically attract tumour cells, J. Pathol, vol.193, pp.367-76, 2001.

A. Farin, S. O. Suzuki, M. Weiker, J. E. Goldman, J. N. Bruce et al., Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis, Glia, vol.53, pp.799-808, 2006.

R. S. Taichman, C. Cooper, E. T. Keller, K. J. Pienta, N. S. Taichman et al., Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone, Cancer Res, vol.62, pp.1832-1839, 2002.

P. Cirillo, D. Rosa, S. Pacileo, M. Gargiulo, A. Angri et al., Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease, J. Thromb. Haemost. Jth, vol.6, pp.726-762, 2008.

A. Watson, M. Olukman, C. Koulis, Y. Tu, D. Samijono et al., Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes, Diabetologia, 2013.

M. Monterrubio, M. Mellado, A. C. Carrera, and J. M. Rodríguez-frade, PI3Kgamma activation by CXCL12 regulates tumor cell adhesion and invasion, Biochem. Biophys. Res. Commun, vol.388, pp.199-204, 2009.

A. M. Glodek, M. Honczarenko, Y. Le, J. J. Campbell, and L. E. Silberstein, Sustained Activation of Cell Adhesion Is a Differentially Regulated Process in B Lymphopoiesis, J. Exp. Med, vol.197, pp.461-73, 2003.

T. Kinashi, Intracellular signalling controlling integrin activation in lymphocytes, Nat. Rev. Immunol, vol.5, pp.546-59, 2005.

S. Matsusaka and I. Wakabayashi, Enhancement of vascular smooth muscle cell migration by urotensin II, Naunyn. Schmiedebergs Arch. Pharmacol, vol.373, pp.381-387, 2006.

N. Sugimoto, N. Takuwa, H. Okamoto, S. Sakurada, and Y. Takuwa, Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor Isoform, Mol. Cell. Biol, vol.23, pp.1534-1579, 2003.

N. A. Hotchin and A. Hall, The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases, J. Cell Biol, vol.131, pp.1857-65, 1995.

C. D. Nobes and A. Hall, Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia, Cell, vol.81, pp.53-62, 1995.

M. Nieto, J. Frade, D. Sancho, M. Mellado, -. Martinez et al., Polarization of Chemokine Receptors to the Leading Edge during Lymphocyte Chemotaxis, J. Exp. Med, vol.186, pp.153-161, 1997.

J. D. Buul, . Van, C. Voermans, J. Gelderen, . Van et al., Leukocyte-Endothelium Interaction Promotes SDF-1-dependent Polarization of CXCR4, J. Biol. Chem, vol.278, pp.30302-30312, 2003.

S. Mañes, R. A. Lacalle, C. Gómez-moutón, M. E. Mart??ez, and -. , Membrane raft microdomains in chemokine receptor function, Semin. Immunol, vol.13, pp.147-57, 2001.

S. Mañes, M. E. Gómez-moutón, C. , A. Lacalle, R. Keller et al., Membrane raft microdomains mediate front-rear polarity in migrating cells, Embo J, vol.18, pp.6211-6231, 1999.

C. Gomez-mouton, Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis, Références bibliographiques -A, vol.164, pp.759-68, 2004.

A. M. Abdelrahman and C. C. Pang, Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats, Life Sci, vol.71, pp.819-825, 2002.

A. E. Abdel-razik, E. J. Forty, R. J. Balment, A. , and N. , Renal haemodynamic and tubular actions of urotensin II in the rat, J. Endocrinol, vol.198, pp.617-624, 2008.

M. Abercrombie and G. A. Dunn, Adhesions of fibroblasts to substratum during contact inhibition observed by interference reflection microscopy, Exp. Cell Res, vol.92, pp.57-62, 1975.

M. Abercrombie, J. E. Heaysman, and S. M. Pegrum, The locomotion of fibroblasts in culture. I. Movements of the leading edge, Exp. Cell Res, vol.59, pp.393-398, 1970.

M. Abercrombie, J. E. Heaysman, and S. M. Pegrum, The locomotion of fibroblasts in culture. IV. Electron microscopy of the leading lamella, Exp. Cell Res, vol.67, pp.359-367, 1971.

R. Abounader and J. Laterra, Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis, Neuro-Oncol, vol.7, pp.436-451, 2005.

J. C. Adams, Roles of fascin in cell adhesion and motility, Curr. Opin. Cell Biol, vol.16, pp.590-596, 2004.

A. Adini, T. Kornaga, F. Firoozbakht, and L. E. Benjamin, Placental growth factor is a survival factor for tumor endothelial cells and macrophages, Cancer Res, vol.62, pp.2749-2752, 2002.

M. Aghi, K. S. Cohen, R. J. Klein, D. T. Scadden, and E. A. Chiocca, Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes, Cancer Res, vol.66, pp.9054-9064, 2006.

A. Ahlbom, M. Feychting, A. Green, L. Kheifets, D. A. Savitz et al., Epidemiologic evidence on mobile phones and tumor risk: a review, Epidemiol. Camb. Mass, vol.20, pp.639-652, 2009.

S. Ahmed, W. I. Goh, and W. Bu, 2010) I-BAR domains, IRSp53 and filopodium formation, Semin. Cell Dev. Biol, vol.21, pp.350-356

S. J. Ahn and I. Kim, Spinal cord glioblastoma induced by radiation therapy of nasopharyngeal rhabdomyosarcoma with MRI findings: case report, Korean J. Radiol. Off. J. Korean Radiol. Soc, vol.13, pp.652-657, 2012.

Y. Aita, T. Kasahara, K. Isobe, Y. Kawakami, and K. Takekoshi, Effect of urotensin II on PC12 rat pheochromocytoma cells, J. Neuroendocrinol, vol.22, pp.83-91, 2010.

G. Albertin, V. Casale, A. Ziolkowska, R. Spinazzi, L. K. Malendowicz et al., Urotensin-II and UII-receptor expression and function in the rat adrenal cortex, Int. J. Mol. Med, vol.17, pp.1111-1115, 2006.

G. Albertin, D. Guidolin, E. Sorato, B. Oselladore, C. Tortorella et al., Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells, Regul. Pept, vol.172, pp.16-22, 2011.

G. Albertin, D. Guidolin, E. Sorato, R. Spinazzi, A. Mascarin et al., Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations, Regul. Pept, vol.157, pp.64-71, 2009.

A. Y. Alexandrova, K. Arnold, S. Schaub, J. M. Vasiliev, J. Meister et al., Comparative Dynamics of Retrograde Actin Flow and Focal Adhesions: Formation of Nascent Adhesions Triggers Transition from Fast to Slow Flow, Plos One, vol.3, p.3234, 2008.

J. Allmer, Existing bioinformatics tools for the quantitation of post-translational modifications, Amino Acids, vol.42, pp.129-138, 2012.

R. L. Alterman and E. R. Stanley, Colony stimulating factor-1 expression in human glioma, Mol. Chem. Neuropathol. Spons. Int. Soc. Neurochem. World Fed. Neurol. Res. Groups Neurochem. Cerebrospinal Fluid, vol.21, pp.177-188, 1994.

R. S. Ames, H. M. Sarau, J. K. Chambers, R. N. Willette, N. V. Aiyar et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, Nature, vol.401, pp.282-286, 1999.

R. S. Ames, H. M. Sarau, J. K. Chambers, R. N. Willette, N. V. Aiyar et al., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14, Nature, vol.401, pp.282-286, 1999.

K. Ando, Y. Obara, J. Sugama, A. Kotani, N. Koike et al., receptor-Gq/11 signaling at lipid rafts is required for UTP-induced cell migration in NG 108-15 cells, J. Pharmacol. Exp. Ther, vol.334, pp.809-819, 2010.

J. Andreev, M. L. Galisteo, O. Kranenburg, S. K. Logan, E. S. Chiu et al., Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade, J. Biol. Chem, vol.276, pp.20130-20135, 2001.

R. K. Andrews and J. E. Fox, Identification of a region in the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX complex that binds to purified actin-binding protein, J. Biol. Chem, vol.267, pp.18605-18611, 1992.

E. Anselmi, D. Vallisa, R. Bertè, C. Vanzo, and L. Cavanna, Post-traumatic glioma: report of two cases, Tumori, vol.92, pp.175-177, 2006.

Y. Arai, T. Kubota, T. Nakagawa, M. Kabuto, K. Sato et al., Production of urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor-1 (PAI-1) in human brain tumours, Acta Neurochir, vol.140, pp.385-386, 1998.

D. E. Arnold-reed and R. J. Balment, Peptide hormones influence in vitro interrenal secretion of cortisol in the trout, Oncorhynchus mykiss, Gen. Comp. Endocrinol, vol.96, pp.85-91, 1994.

W. T. Arthur, L. A. Petch, and K. Burridge, Integrin engagement suppresses RhoA activity via a c-Src-dependent mechanism, Curr. Biol. Cb, vol.10, pp.719-722, 2000.

T. K. Attwood and J. B. Findlay, Fingerprinting G-protein-coupled receptors, Protein Eng, vol.7, pp.195-203, 1994.

E. Audero, I. Cascone, I. Zanon, S. C. Previtali, R. Piva et al., Expression of Angiopoietin-1 in Human Glioblastomas Regulates Tumor-Induced Angiogenesis In Vivo and In Vitro Studies, Arterioscler. Thromb. Vasc. Biol, vol.21, pp.536-541, 2001.

P. Auguste, D. B. Gürsel, S. Lemière, D. Reimers, P. Cuevas et al., Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and -independent mechanisms, Cancer Res, vol.61, pp.1717-1726, 2001.

H. G. Augustin, G. Y. Koh, G. Thurston, A. , and K. , Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system, Nat. Rev. Mol. Cell Biol, vol.10, pp.165-177, 2009.

H. Awata, C. Huang, M. E. Handlogten, and R. T. Miller, Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein, J. Biol. Chem, vol.276, pp.34871-34879, 2001.

M. A. Ayoub, C. Couturier, E. Lucas-meunier, S. Angers, P. Fossier et al., Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer, J. Biol. Chem, vol.277, pp.21522-21528, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00171298

G. J. Babcock, M. Farzan, and J. Sodroski, Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor, J. Biol. Chem, vol.278, pp.3378-3385, 2003.

B. Badie and J. Schartner, Role of microglia in glioma biology, Microsc. Res. Tech, vol.54, pp.106-113, 2001.

B. Badie, J. Schartner, J. Klaver, and J. Vorpahl, In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor, Neurosurgery, vol.44, pp.1082-1083, 1999.

M. Baggiolini, A. Walz, and S. L. Kunkel, Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils, J. Clin. Invest, vol.84, pp.1045-1049, 1989.

P. Bailey and H. Cushing, A classification of the tumors of the glioma group on a histogenic basis with a correlated study of prognosis, J B Lippincott Co. Philadelphia, 1926.

A. Bajetto, F. Barbieri, A. Dorcaratto, S. Barbero, A. Daga et al., Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration, Neurochem. Int, vol.49, pp.423-432, 2006.

N. Q. Balaban, U. S. Schwarz, D. Riveline, P. Goichberg, G. Tzur et al., Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates, Nat. Cell Biol, vol.3, pp.466-472, 2001.

A. Balat, M. Karakök, K. Yilmaz, and Y. Kibar, Urotensin-II immunoreactivity in children with chronic glomerulonephritis, Ren. Fail, vol.29, pp.573-578, 2007.

R. T. Baldwin and S. Preston-martin, Epidemiology of brain tumors in childhood--a review, Toxicol. Appl. Pharmacol, vol.199, pp.118-131, 2004.

Y. Ban, T. Watanabe, T. Suguro, T. Matsuyama, Y. Iso et al., Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia, J. Atheroscler. Thromb, vol.16, pp.179-187, 2009.

F. Barbieri, A. Pattarozzi, M. Gatti, C. Aiello, A. Quintero et al., Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice, Am. J. Physiol. Endocrinol. Metab, vol.297, pp.1078-1088, 2009.

W. G. Barnes, E. Reiter, J. D. Violin, X. Ren, G. Milligan et al., ) beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation, J. Biol. Chem, vol.280, pp.8041-8050, 2005.

L. F. Barros, T. Kanaseki, R. Sabirov, S. Morishima, J. Castro et al., Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency, Cell Death Differ, vol.10, pp.687-697, 2003.

M. S. Batuwangala, G. Calo, R. Guerrini, L. L. Ng, J. Mcdonald et al., Desensitisation of native and recombinant human urotensin-II receptors, Naunyn. Schmiedebergs Arch. Pharmacol, vol.380, pp.451-457, 2009.

T. H. Bayburt, S. A. Vishnivetskiy, M. A. Mclean, T. Morizumi, C. Huang et al., Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding, J. Biol. Chem, vol.286, pp.1420-1428, 2011.

L. Becciolini, E. Meacci, C. Donati, F. Cencetti, E. Rapizzi et al., Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts, Biochim. Biophys. Acta Bba -Mol. Cell Biol. Lipids, vol.1761, pp.43-51, 2006.

D. J. Behm, N. V. Aiyar, A. R. Olzinski, J. J. Mcatee, M. A. Hilfiker et al., GSK1562590, a slowly dissociating urotensin-II receptor antagonist, exhibits prolonged pharmacodynamic activity ex vivo, Br. J. Pharmacol, vol.161, pp.207-228, 2010.

D. J. Behm, C. P. Doe, D. G. Johns, K. Maniscalco, G. P. Stankus et al., Urotensin-II: a novel systemic hypertensive factor in the cat, Naunyn. Schmiedebergs Arch. Pharmacol, vol.369, pp.274-280, 2004.

D. J. Behm, C. L. Herold, V. Camarda, N. V. Aiyar, and S. A. Douglas, Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors, Eur. J. Pharmacol, vol.492, pp.113-116, 2004.

D. J. Behm, C. L. Herold, E. H. Ohlstein, S. D. Knight, D. Dhanak et al., Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpaamide), a novel peptidic urotensin-II receptor antagonist, Br. J. Pharmacol, vol.137, pp.449-458, 2002.

D. J. Behm, J. J. Mcatee, J. W. Dodson, M. J. Neeb, H. E. Fries et al., Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues, Br. J. Pharmacol, vol.155, pp.374-386, 2008.

D. J. Behm, G. Stankus, C. P. Doe, R. N. Willette, H. M. Sarau et al., The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems, Br. J. Pharmacol, vol.148, pp.173-190, 2006.

S. Behrem, K. Zarkovi?, N. Eskinja, J. , and N. , Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation, Pathol. Oncol. Res. Por, vol.11, pp.229-235, 2005.

S. L. Bellis, J. A. Perrotta, M. S. Curtis, and C. E. Turner, Adhesion of fibroblasts to fibronectin stimulates both serine and tyrosine phosphorylation of paxillin, Biochem. J, vol.325, pp.375-381, 1997.

L. Bello, M. Francolini, P. Marthyn, J. Zhang, R. S. Carroll et al., Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery, Neurosurgery, vol.49, pp.380-389, 2001.

L. Bello, C. Giussani, G. Carrabba, M. Pluderi, F. Costa et al., Angiogenesis and invasion in gliomas, Cancer Treat. Res, vol.117, pp.263-284, 2004.

N. W. Bengtson and D. I. Linzer, Inhibition of tumor growth by the antiangiogenic placental hormone, proliferin-related protein, Mol. Endocrinol. Baltim. Md, vol.14, pp.1934-1943, 2000.

K. A. Beningo, M. Dembo, I. Kaverina, J. V. Small, W. et al., Nascent Focal Adhesions Are Responsible for the Generation of Strong Propulsive Forces in Migrating Fibroblasts, J. Cell Biol, vol.153, pp.881-888, 2001.

G. Bergers and L. E. Benjamin, Tumorigenesis and the angiogenic switch, Nat. Rev. Cancer, vol.3, pp.401-410, 2003.

H. A. Bern and K. Lederis, A reference preparation for the study of active substances in the caudal neurosecretory system of teleosts, J. Endocrinol, vol.45, 1969.

M. Bernfield and R. D. Sanderson, Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors, Philos. Trans. R. Soc. Lond. B. Biol. Sci, vol.327, pp.171-186, 1990.

I. Bettinger, S. Thanos, and W. Paulus, Microglia promote glioma migration, Acta Neuropathol. (Berl.), vol.103, pp.351-355, 2002.

D. Bian, C. Mahanivong, J. Yu, S. M. Frisch, Z. K. Pan et al., The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration, Oncogene, vol.25, pp.2234-2244, 2006.

R. Bianca, V. Di, E. Mitidieri, F. Fusco, E. D'aiuto et al., Endogenous urotensin II selectively modulates erectile function through eNOS, Plos One, vol.7, p.31019, 2012.

M. Birker-robaczewska, C. Boukhadra, R. Studer, C. Mueller, C. Binkert et al., The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma, J. Recept. Signal Transduct. Res, vol.23, pp.289-305, 2003.

B. Birlik, S. Canda, and E. Ozer, Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas, Neuropathol. Appl. Neurobiol, vol.32, pp.532-538, 2006.

G. W. Bisset and G. P. Lewis, A spectrum of pharmacological activity in some biologically active peptides, Br. J. Pharmacol. Chemother, vol.19, pp.168-182, 1962.

V. Bizzarro, R. Belvedere, F. Dal-piaz, L. Parente, and A. Petrella, Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors, Plos One, vol.7, p.48246, 2012.

J. D. Bjorge, T. O. Chan, M. Antczak, H. J. Kung, and D. J. Fujita, Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation, Proc. Natl. Acad. Sci. U. S. A, vol.87, pp.3816-3820, 1990.

J. Bockaert, P. Marin, A. Dumuis, and L. Fagni, The "magic tail" of G protein-coupled receptors: an anchorage for functional protein networks, Febs Lett, vol.546, pp.65-72, 2003.

F. Böhm and J. Pernow, Urotensin II evokes potent vasoconstriction in humans in vivo, Br. J. Pharmacol, vol.135, pp.25-27, 2002.

S. Boivin, L. Guilhaudis, I. Milazzo, H. Oulyadi, D. Davoust et al., Characterization of urotensin-II receptor structural domains involved in the recognition of U-II, URP, and urantide, Biochemistry (Mosc.), vol.45, pp.5993-6002, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-00820020

S. Boivin, I. Ségalas-milazzo, L. Guilhaudis, H. Oulyadi, A. Fournier et al., Solution structure of urotensin-II receptor extracellular loop III and characterization of its interaction with urotensin-II, Peptides, vol.29, pp.700-710, 2008.
URL : https://hal.archives-ouvertes.fr/hal-02352152

G. M. Bokoch, C. J. Vlahos, Y. Wang, U. G. Knaus, and A. E. Traynor-kaplan, Rac GTPase interacts specifically with phosphatidylinositol 3-kinase, Biochem. J, vol.315, pp.775-779, 1996.

L. Bondesson, K. Norolind, S. Lidén, G. Gafvelin, E. Theodorsson et al., Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration, Acta Physiol. Scand, vol.141, pp.477-481, 1991.

F. E. Bottrill, S. A. Douglas, C. R. Hiley, and R. White, Human urotensin-II is an endotheliumdependent vasodilator in rat small arteries, Br. J. Pharmacol, vol.130, pp.1865-1870, 2000.

A. A. Boucard, S. S. Sauvé, G. Guillemette, E. Escher, and R. Leduc, Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain, Biochem. J, vol.370, pp.829-838, 2003.

N. Bousette, F. Hu, E. H. Ohlstein, D. Dhanak, S. A. Douglas et al., Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation, J. Mol. Cell. Cardiol, vol.41, pp.285-295, 2006.

N. Bousette, L. Patel, S. A. Douglas, E. H. Ohlstein, and A. Giaid, Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta, Atherosclerosis, vol.176, pp.117-123, 2004.

N. Bousette, J. Pottinger, W. Ramli, E. H. Ohlstein, D. Dhanak et al., Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease, Peptides, vol.27, pp.2919-2926, 2006.

E. P. Bowman, J. J. Campbell, K. M. Druey, A. Scheschonka, J. H. Kehrl et al., Regulation of chemotactic and proadhesive responses to chemoattractant receptors by RGS (regulator of G-protein signaling) family members, J. Biol. Chem, vol.273, pp.28040-28048, 1998.

E. Brailoiu, X. Jiang, G. C. Brailoiu, J. Yang, J. K. Chang et al., Statedependent calcium mobilization by urotensin-II in cultured human endothelial cells, Peptides, vol.29, pp.721-726, 2008.

S. D. Brain, T. J. Williams, J. R. Tippins, H. R. Morris, and I. Macintyre, Calcitonin generelated peptide is a potent vasodilator, Nature, vol.313, pp.54-56, 1985.

D. J. Brat, A. C. Bellail, and E. G. Van-meir, The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis, Neuro-Oncol, vol.7, pp.122-133, 2005.

D. J. Brat, A. C. Bellail, and E. G. Van-meir, The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis, Neuro-Oncol, vol.7, pp.122-133, 2005.

D. Breitsprecher, A. K. Kiesewetter, J. Linkner, M. Vinzenz, T. E. Stradal et al., Molecular mechanism of Ena/VASP-mediated actin-filament elongation, Embo J, vol.30, pp.456-467, 2011.

S. Brem, The role of vascular proliferation in the growth of brain tumors, Clin. Neurosurg, vol.23, pp.440-453, 1976.

A. Brkovic, A. Hattenberger, E. Kostenis, T. Klabunde, S. Flohr et al., Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay, J. Pharmacol. Exp. Ther, vol.306, pp.1200-1209, 2003.

M. Brockmann, U. Ulbricht, K. Grüner, R. Fillbrandt, M. Westphal et al., Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors, Neurosurgery, vol.52, pp.1391-1399, 2003.

M. C. Brown and C. E. Turner, Characterization of paxillin LIM domain-associated serine threonine kinases: activation by angiotensin II in vascular smooth muscle cells, J. Cell. Biochem, vol.76, pp.99-108, 1999.

M. C. Brown and C. E. Turner, Paxillin: Adapting to Change, Physiol. Rev, vol.84, pp.1315-1339, 2004.

S. L. Brown, V. R. Jala, S. K. Raghuwanshi, M. W. Nasser, B. Haribabu et al., Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals, J. Immunol. Baltim. Md, vol.177, pp.3242-3249, 1950.

M. K. Brunckhorst, H. Wang, R. Lu, Y. , and Q. , Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis, Cancer Res, vol.70, pp.7283-7293, 2010.

P. Büchler, H. A. Reber, J. S. Tomlinson, O. Hankinson, G. Kallifatidis et al., Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer, Neoplasia New York N, vol.11, pp.196-206, 2009.

A. M. Buhl, N. L. Johnson, N. Dhanasekaran, J. , and G. L. , G?12 and G?13 Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly, J. Biol. Chem, vol.270, pp.24631-24634, 1995.

P. D. Burbelo, D. Drechsel, and A. Hall, A Conserved Binding Motif Defines Numerous Candidate Target Proteins for Both Cdc42 and Rac GTPases, J. Biol. Chem, vol.270, pp.29071-29074, 1995.

S. M. Burden-gulley, M. Q. Qutaish, K. E. Sullivant, H. Lu, J. Wang et al., Novel cryo-imaging of the glioma tumor microenvironment reveals migration and dispersal pathways in vivid three-dimensional detail, Cancer Res, vol.71, pp.5932-5940, 2011.

B. Bussolati, L. Biancone, P. Cassoni, S. Russo, M. Rola-pleszczynski et al., PAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis, Am. J. Pathol, vol.157, pp.1713-1725, 2000.

J. D. Buul, . Van, C. Voermans, J. Gelderen, . Van et al., Leukocyte-Endothelium Interaction Promotes SDF-1-dependent Polarization of CXCR4, J. Biol. Chem, vol.278, pp.30302-30310, 2003.

V. Camarda, R. Guerrini, E. Kostenis, A. Rizzi, G. Calò et al., A new ligand for the urotensin II receptor, Br. J. Pharmacol, vol.137, pp.311-314, 2002.

V. Camarda, W. Song, E. Marzola, M. Spagnol, R. Guerrini et al., Urantide mimics urotensin-II induced calcium release in cells expressing recombinant UT receptors, Eur. J. Pharmacol, vol.498, pp.83-86, 2004.

V. Camarda, M. Spagnol, W. Song, R. Vergura, A. L. Roth et al., In vitro and in vivo pharmacological characterization of the novel UT receptor ligand, Br. J. Pharmacol, vol.147, pp.92-100, 2006.

K. G. Campellone and M. D. Welch, A nucleator arms race: cellular control of actin assembly, Nat. Rev. Mol. Cell Biol, vol.11, pp.237-251, 2010.

A. Carotenuto, P. Grieco, P. Campiglia, E. Novellino, and P. Rovero, Unraveling the active conformation of urotensin II, J. Med. Chem, vol.47, pp.1652-1661, 2004.

H. Castel, M. Diallo, D. Chatenet, J. Leprince, L. Desrues et al., Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes, J. Neurochem, vol.99, pp.582-595, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01960748

P. Castellani, G. Viale, A. Dorcaratto, G. Nicolo, J. Kaczmarek et al., The fibronectin isoform containing the ed-b oncofetal domain: A marker of angiogenesis, Int. J. Cancer, vol.59, pp.612-618, 1994.

M. G. Cattaneo, B. Chini, and L. M. Vicentini, Oxytocin stimulates migration and invasion in human endothelial cells, Br. J. Pharmacol, vol.153, pp.728-736, 2008.

M. Chabbert, H. Castel, J. Pele, J. Deville, R. Legendre et al., Evolution of class A G-protein-coupled receptors: implications for molecular modeling, Curr. Med. Chem, vol.19, pp.1110-1118, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02286182

C. Chakraborty, Y. P. Barbin, S. Chakrabarti, P. Chidiac, S. J. Dixon et al., Endothelin-1 promotes migration and induces elevation of [Ca2+]i and phosphorylation of MAP kinase of a human extravillous trophoblast cell line, Mol. Cell. Endocrinol, vol.201, pp.63-73, 2003.

K. T. Chan, D. A. Bennin, and A. Huttenlocher, Regulation of adhesion dynamics by calpainmediated proteolysis of focal adhesion kinase (FAK), J. Biol. Chem, vol.285, pp.11418-11426, 2010.

J. Chant and J. R. Pringle, Budding and cell polarity in Saccharomyces cerevisiae, Curr. Opin. Genet. Dev, vol.1, pp.342-350, 1991.

W. Chao and J. Kunz, Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins, Febs Lett, vol.583, pp.1337-1343, 2009.

I. F. Charo and M. B. Taubman, Chemokines in the pathogenesis of vascular disease, Circ. Res, vol.95, pp.858-866, 2004.

G. T. Charras, M. Coughlin, T. J. Mitchison, and L. Mahadevan, Life and Times of a Cellular Bleb, Biophys. J, vol.94, pp.1836-1853, 2008.

N. Chartrel, J. M. Conlon, F. Collin, B. Braun, D. Waugh et al., Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical localization and biochemical characterization, J. Comp. Neurol, vol.364, pp.324-339, 1996.

D. Chatenet, C. Dubessy, J. Leprince, C. Boularan, L. Carlier et al., Structure-activity relationships and structural conformation of a novel urotensin II-related peptide, Peptides, vol.25, pp.1819-1830, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01960815

D. Chatenet, Q. Nguyen, M. Létourneau, J. Dupuis, and A. Fournier, Urocontrin, a novel UT receptor ligand with a unique pharmacological profile, Biochem. Pharmacol, vol.83, pp.608-615, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01001676

D. Chatenet, T. M. Nguyen, M. Létourneau, and A. Fournier, Update on the urotensinergic system: new trends in receptor localization, activation, and drug design, Front. Endocrinol, vol.3, p.174, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01001636

G. Chen, Y. Cheng, Y. Tang, M. Martinka, L. et al., Role of Tip60 in human melanoma cell migration, metastasis, and patient survival, J. Invest. Dermatol, vol.132, pp.2632-2641, 2012.

W. T. Chen, Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells, J. Exp. Zool, vol.251, pp.167-185, 1989.

W. T. Chen, E. Hasegawa, T. Hasegawa, C. Weinstock, and K. M. Yamada, Development of cell surface linkage complexes in cultured fibroblasts, J. Cell Biol, vol.100, pp.1103-1114, 1985.

Y. Chen, M. Zhao, X. Liu, W. Yao, J. Yang et al., Urotensin II receptor in the rat airway smooth muscle and its effect on the rat airway smooth muscle cells proliferation, Chin. Med. Sci. J. Chung-Kuo Hsüeh Ko Hsüeh Tsa Chih Chin. Acad. Med. Sci, vol.16, pp.231-235, 2001.

Y. Chen, J. Liu, S. Loh, C. Chen, C. Hong et al., Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts, Eur. J. Pharmacol, vol.593, pp.24-29, 2008.

Y. Chen, S. Loh, J. Chen, and C. Tsai, Urotensin II prevents cardiomyocyte apoptosis induced by doxorubicin via Akt and ERK, Eur. J. Pharmacol, vol.680, pp.88-94, 2012.

Z. Chen, Q. Yang, Y. Huang, L. Fan, X. Li et al., Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery, Vascul. Pharmacol, vol.52, pp.70-76, 2010.

J. Cheriyan, T. J. Burton, T. J. Bradley, S. M. Wallace, K. M. Mäki-petäjä et al., The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans, Br. J. Clin. Pharmacol, vol.68, pp.518-523, 2009.

C. Chetty, S. K. Vanamala, C. S. Gondi, D. H. Dinh, M. Gujrati et al., MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells, Cell. Signal, vol.24, pp.549-559, 2012.

B. M. Cheung, R. Leung, Y. B. Man, and L. Y. Wong, Plasma concentration of urotensin II is raised in hypertension, J. Hypertens, vol.22, pp.1341-1344, 2004.

E. S. Chhabra and H. N. Higgs, The many faces of actin: matching assembly factors with cellular structures, Nat. Cell Biol, vol.9, pp.1110-1121, 2007.

M. R. Chicoine and D. L. Silbergeld, Mitogens as motogens, J. Neurooncol, vol.35, pp.249-257, 1997.

A. Chlenski, L. J. Guerrero, R. Peddinti, J. A. Spitz, P. T. Leonhardt et al., Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors, Mol. Cancer, vol.9, p.138, 2010.

C. K. Choi, M. Vicente-manzanares, J. Zareno, L. A. Whitmore, A. Mogilner et al., Actin and ?-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner, Nat. Cell Biol, vol.10, p.1039, 2008.

C. K. Choi, J. Zareno, M. A. Digman, E. Gratton, and A. R. Horwitz, Cross-Correlated Fluctuation Analysis Reveals Phosphorylation-Regulated Paxillin-FAK Complexes in Nascent Adhesions, Biophys. J, vol.100, pp.583-592, 2011.

G. L. Christensen, C. D. Kelstrup, C. Lyngsø, U. Sarwar, R. Bøgebo et al., Quantitative Phosphoproteomics Dissection of Seventransmembrane Receptor Signaling Using Full and Biased Agonists, Mol. Cell. Proteomics, vol.9, pp.1540-1553, 2010.

M. Chrzanowska-wodnicka and K. Burridge, Rho-stimulated contractility drives the formation of stress fibers and focal adhesions, J. Cell Biol, vol.133, pp.1403-1415, 1996.

C. Y. Chung, S. Funamoto, and R. A. Firtel, Signaling pathways controlling cell polarity and chemotaxis, Trends Biochem. Sci, vol.26, pp.557-566, 2001.

P. Cirillo, S. De-rosa, M. Pacileo, A. Gargiulo, V. Angri et al., Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease, J. Thromb. Haemost. Jth, vol.6, pp.726-736, 2008.

A. Claing, S. A. Laporte, M. G. Caron, and R. J. Lefkowitz, Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and ß-arrestin proteins, Prog. Neurobiol, vol.66, pp.61-79, 2002.

S. .. Clark, H. Nothacker, Z. Wang, Y. Saito, F. Leslie et al., The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat, Brain Res, vol.923, pp.120-127, 2001.

T. F. Cloughesy, K. Yoshimoto, P. Nghiemphu, K. Brown, J. Dang et al., Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma, Plos Med, vol.5, p.8, 2008.

M. Clozel, C. Binkert, M. Birker-robaczewska, C. Boukhadra, S. Ding et al., -methylquinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System, J. Pharmacol. Exp. Ther, vol.1, issue.2, pp.204-212, 2004.

M. Clozel, P. Hess, C. Qiu, S. Ding, R. et al., The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats, J. Pharmacol. Exp. Ther, vol.316, pp.1115-1121, 2006.

J. S. Condeelis, J. B. Wyckoff, M. Bailly, R. Pestell, D. Lawrence et al., Lamellipodia in invasion. Semin. Cancer Biol, vol.11, pp.119-128, 2001.

S. J. Coniglio, E. Eugenin, K. Dobrenis, E. R. Stanley, B. L. West et al., Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling, Mol. Med. Camb. Mass, vol.18, pp.519-527, 2012.

J. M. Conlon, D. Arnold-reed, and R. J. Balment, Post-translational processing of preprourotensin II, Febs Lett, vol.266, pp.37-40, 1990.

J. M. Conlon, F. O'harte, D. D. Smith, R. J. Balment, and N. Hazon, Purification and characterization of urotensin II and parvalbumin from an elasmobranch fish, Scyliorhinus canicula (common dogfish), Neuroendocrinology, vol.55, pp.230-235, 1992.

J. M. Conlon, F. O'harte, D. D. Smith, M. C. Tonon, and H. Vaudry, Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda, Biochem. Biophys. Res. Commun, vol.188, pp.578-583, 1992.

J. M. Conlon, H. Tostivint, and H. Vaudry, Somatostatin-and urotensin II-related peptides: molecular diversity and evolutionary perspectives, Regul. Pept, vol.69, pp.95-103, 1997.

P. J. Coopman, M. T. Do, E. W. Thompson, and S. C. Mueller, Phagocytosis of Cross-Linked Gelatin Matrix by Human Breast Carcinoma Cells Correlates with Their Invasive Capacity, Clin. Cancer Res, vol.4, pp.507-515, 1998.

C. L. Cortesio, L. R. Boateng, T. M. Piazza, D. A. Bennin, and A. Huttenlocher, Calpainmediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration, J. Biol. Chem, vol.286, pp.9998-10006, 2011.

M. C. Côté, J. R. Lavoie, F. Houle, A. Poirier, S. Rousseau et al., Regulation of vascular endothelial growth factor-induced endothelial cell migration by LIM kinase 1-mediated phosphorylation of annexin 1, J. Biol. Chem, vol.285, pp.8013-8021, 2010.

M. Cotton and A. Claing, G protein-coupled receptors stimulation and the control of cell migration, Cell. Signal, vol.21, pp.1045-1053, 2009.

J. R. Couchman and D. A. Rees, Actomyosin organisation for adhesion, spreading, growth and movement in chick fibroblasts, Cell Biol. Int. Rep, vol.3, pp.431-439, 1979.

Y. Coulouarn, C. Fernex, S. Jégou, C. E. Henderson, H. Vaudry et al., Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord, Mech. Dev, vol.101, pp.187-190, 2001.

Y. Coulouarn, S. Jégou, H. Tostivint, H. Vaudry, and I. Lihrmann, Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors, Febs Lett, vol.457, pp.28-32, 1999.

Y. Coulouarn, I. Lihrmann, S. Jegou, Y. Anouar, H. Tostivint et al., Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.15803-15808, 1998.

E. Cowley, J. P. Thompson, P. Sharpe, J. Waugh, N. Ali et al., Effects of preeclampsia on maternal plasma, cerebrospinal fluid, and umbilical cord urotensin II concentrations: a pilot study, Br. J. Anaesth, vol.95, pp.495-499, 2005.

D. R. Critchley, Smurf1 zaps the talin head, Nat. Cell Biol, vol.11, pp.538-540, 2009.

D. E. Croall and G. N. Demartino, Calcium-activated neutral protease (calpain) system: structure, function, and regulation, Physiol. Rev, vol.71, pp.813-847, 1991.

G. E. Croston, R. Olsson, E. A. Currier, E. S. Burstein, D. Weiner et al., Discovery of the first nonpeptide agonist of the GPR14/urotensin-II receptor: 3-(4-chlorophenyl)-3-(2-(dimethylamino)ethyl)isochroman-1-one (AC-7954), J. Med. Chem, vol.45, pp.4950-4953, 2002.

E. Crowley and A. F. Horwitz, Tyrosine phosphorylation and cytoskeletal tension regulate the release of fibroblast adhesions, J. Cell Biol, vol.131, pp.525-537, 1995.

P. Cuevas, F. Carceller, D. Reimers, B. Cuevas, R. M. Lozano et al., Inhibition of intra-tumoral angiogenesis and glioma growth by the fibroblast growth factor inhibitor 1,3,6-naphthalenetrisulfonate, Neurol. Res, vol.21, pp.481-487, 1999.

C. C. Cunningham, Actin polymerization and intracellular solvent flow in cell surface blebbing, J. Cell Biol, vol.129, pp.1589-1599, 1995.

M. G. Currie, D. M. Geller, B. R. Cole, J. G. Boylan, W. Yusheng et al., Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria, Science, vol.221, pp.71-73, 1983.

A. S. Curtis, The mechanism of adhesion of cells to glass. a study by interference reflection microscopy, J. Cell Biol, vol.20, pp.199-215, 1964.

S. Cvejic and L. A. Devi, Dimerization of the delta opioid receptor: implication for a role in receptor internalization, J. Biol. Chem, vol.272, pp.26959-26964, 1997.

Z. Daher, J. Noël, and A. Claing, Endothelin-1 promotes migration of endothelial cells through the activation of ARF6 and the regulation of FAK activity, Cell. Signal, vol.20, pp.2256-2265, 2008.

H. Dai, X. Guo, Z. Ge, Z. Li, X. Yu et al., Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy, J. Diabetes Complications, vol.22, pp.137-143, 2008.

H. Dai, T. He, X. Li, W. Xu, and Z. Ge, Urotensin-2 promotes collagen synthesis via ERK1/2-dependent and ERK1/2-independent TGF-?1 in neonatal cardiac fibroblasts, Cell Biol. Int, vol.35, pp.93-98, 2011.

H. Dai, W. Kang, X. Wang, X. Yu, Z. Li et al., The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts, Regul. Pept, vol.140, pp.88-93, 2007.

H. Daub, F. U. Weiss, C. Wallasch, and A. Ullrich, Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors, Nature, vol.379, pp.557-560, 1996.

R. W. Davenport, P. Dou, V. Rehder, and S. B. Kater, A sensory role for neuronal growth cone filopodia, Nature, vol.361, pp.721-724, 1993.

T. David-pfeuty and S. J. Singer, Altered distributions of the cytoskeletal proteins vinculin and alpha-actinin in cultured fibroblasts transformed by Rous sarcoma virus, Proc. Natl. Acad. Sci, vol.77, p.6687, 1980.

W. A. Davies and T. P. Stossel, Peripheral hyaline blebs (podosomes) of macrophages, J. Cell Biol, vol.75, pp.941-955, 1977.

S. De-boüard, J. Guillamo, C. Christov, N. Lefévre, P. Brugières et al., Antiangiogenic Therapy Against Experimental Glioblastoma Using Genetically Engineered Cells Producing Interferon-?, Angiostatin, or Endostatin. Hum. Gene Ther, vol.14, pp.883-895, 2003.

L. De-lecea and P. Bourgin, Neuropeptide interactions and REM sleep: a role for Urotensin II?, Peptides, vol.29, pp.845-851, 2008.

M. O. De-nichilo and K. M. Yamada, Integrin alpha v beta 5-dependent serine phosphorylation of paxillin in cultured human macrophages adherent to vitronectin, J. Biol. Chem, vol.271, pp.11016-11022, 1996.

D. Oliveira, M. V. Marin, T. M. Clemente, C. F. Costa, A. P. Judice et al., SHP-2 regulates myogenesis by coupling to FAK signaling pathway, Febs Lett, vol.583, pp.2975-2981, 2009.

L. De-vries, B. Zheng, T. Fischer, E. Elenko, and M. G. Farquhar, The regulator of G protein signaling family, Annu. Rev. Pharmacol. Toxicol, vol.40, pp.235-271, 2000.

D. Wever, O. Demetter, P. Mareel, M. Bracke, and M. , Stromal myofibroblasts are drivers of invasive cancer growth, Int. J. Cancer J. Int. Cancer, vol.123, pp.2229-2238, 2008.

F. M. Décaillot, M. A. Kazmi, Y. Lin, S. Ray-saha, T. P. Sakmar et al., CXCR7/CXCR4 Heterodimer Constitutively Recruits ?-Arrestin to Enhance Cell Migration, J. Biol. Chem, vol.286, pp.32188-32197, 2011.

D. Valle-pérez, B. Martínez, V. G. Lacasa-salavert, C. Figueras, A. Shapiro et al., Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2, J. Biol. Chem, vol.285, pp.10748-10760, 2010.

J. A. Depasquale and C. S. Izzard, Evidence for an actin-containing cytoplasmic precursor of the focal contact and the timing of incorporation of vinculin at the focal contact, J. Cell Biol, vol.105, pp.2803-2809, 1987.

E. I. Deryugina and M. A. Bourdon, Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin, J. Cell Sci, vol.109, pp.643-652, 1996.

L. Desrues, T. Lefebvre, M. Diallo, P. Gandolfo, J. Leprince et al., Effect of GABA A receptor activation on UT-coupled signaling pathways in rat cortical astrocytes, Peptides, vol.29, pp.727-734, 2008.

L. Desrues, T. Lefebvre, C. Lecointre, M. Schouft, J. Leprince et al., Down-regulation of GABA(A) receptor via promiscuity with the vasoactive peptide urotensin II receptor. Potential involvement in astrocyte plasticity, Plos One, vol.7, p.36319, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02294501

J. Devillé, J. Rey, and M. Chabbert, An indel in transmembrane helix 2 helps to trace the molecular evolution of class A G-protein-coupled receptors, J. Mol. Evol, vol.68, pp.475-489, 2009.

S. T. Dheen, C. Kaur, and E. Ling, Microglial activation and its implications in the brain diseases, Curr. Med. Chem, vol.14, pp.1189-1197, 2007.

M. Dhodapkar, J. Rubin, J. M. Reid, P. A. Burch, H. C. Pitot et al., Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.3, pp.1093-1100, 1997.

M. Diallo, M. Jarry, L. Desrues, H. Castel, D. Chatenet et al., Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes, Peptides, vol.29, pp.813-819, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01962707

I. Diebold, A. Petry, M. Burger, J. Hess, and A. Görlach, NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II, Mol. Biol. Cell, vol.22, pp.4424-4434, 2011.

I. Diebold, A. Petry, K. Sabrane, T. Djordjevic, J. Hess et al., The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II, J. Cell Sci, vol.125, pp.956-964, 2012.

T. Djordjevic, R. S. Belaiba, S. Bonello, J. Pfeilschifter, J. Hess et al., Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells, Arterioscler. Thromb. Vasc. Biol, vol.25, pp.519-525, 2005.

J. Do-rego, D. Chatenet, M. Orta, B. Naudin, C. Le-cudennec et al., Behavioral effects of urotensin-II centrally administered in mice, Psychopharmacology (Berl.), vol.183, pp.103-117, 2005.
URL : https://hal.archives-ouvertes.fr/hal-01962710

N. D. Doan, T. T. Nguyen, M. Létourneau, K. Turcotte, A. Fournier et al., Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart, Br. J. Pharmacol, vol.166, pp.243-257, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00818552

A. Domogatskaya, S. Rodin, and K. Tryggvason, Functional Diversity of Laminins, Annu. Rev. Cell Dev. Biol, vol.28, pp.523-553, 2012.

S. A. Douglas, D. J. Ashton, C. F. Sauermelch, R. W. Coatney, D. H. Ohlstein et al., Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate, J. Cardiovasc. Pharmacol, vol.36, pp.163-166, 2000.

S. A. Douglas, D. J. Behm, N. V. Aiyar, D. Naselsky, J. Disa et al., Nonpeptidic urotensin-II receptor antagonists I: in vitropharmacological characterization of SB-706375, Br. J. Pharmacol, vol.145, pp.620-635, 2005.

S. A. Douglas, D. Dhanak, and D. G. Johns, From "gills to pills": urotensin-II as a regulator of mammalian cardiorenal function, Trends Pharmacol. Sci, vol.25, pp.76-85, 2004.

S. A. Douglas, D. Naselsky, Z. Ao, J. Disa, C. L. Herold et al., Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines, Br. J. Pharmacol, vol.142, pp.921-932, 2004.

S. A. Douglas and E. H. Ohlstein, Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease, Trends Cardiovasc. Med, vol.10, pp.229-237, 2000.

S. A. Douglas, A. C. Sulpizio, V. Piercy, H. M. Sarau, R. S. Ames et al., Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey, Br. J. Pharmacol, vol.131, pp.1262-1274, 2000.

S. A. Douglas, L. Tayara, E. H. Ohlstein, N. Halawa, and A. Giaid, Congestive heart failure and expression of myocardial urotensin II, Lancet, vol.359, 1990.

J. A. Dowell, J. A. Johnson, L. , and L. , Identification of Astrocyte Secreted Proteins with a Combination of Shotgun Proteomics and Bioinformatics, J. Proteome Res, vol.8, pp.4135-4143, 2009.

J. Downward, R. Riehl, L. Wu, and R. A. Weinberg, Identification of a nucleotide exchangepromoting activity for p21ras, Proc. Natl. Acad. Sci. U. S. A, vol.87, pp.5998-6002, 1990.

D. G. Drubin and W. J. Nelson, Origins of cell polarity, Cell, vol.84, pp.335-344, 1996.

T. Dschietzig, C. Bartsch, R. Pregla, H. R. Zurbrügg, F. P. Armbruster et al., Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure, Regul. Pept, vol.110, pp.33-38, 2002.

C. Dubessy, D. Cartier, B. Lectez, C. Bucharles, N. Chartrel et al., Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction, J. Neurochem, vol.107, pp.361-374, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01962726

S. L. Dun, G. C. Brailoiu, J. Yang, J. K. Chang, and N. J. Dun, Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat, Neurosci. Lett, vol.305, pp.9-12, 2001.

J. D. Dunn, G. E. Reid, and M. L. Bruening, Techniques for phosphopeptide enrichment prior to analysis by mass spectrometry, Mass Spectrom. Rev, vol.29, pp.29-54, 2010.

C. Eckerich, S. Zapf, R. Fillbrandt, S. Loges, M. Westphal et al., Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration, Int. J. Cancer J. Int. Cancer, vol.121, pp.276-283, 2007.

K. Edvardsen, P. Pedersen, R. Bjerkvig, G. G. Hermann, J. Zeuthen et al., Transfection of glioma cells with the neural-cell adhesion molecule NCAM: Effect on glioma-cell invasion and growth in vivo, Int. J. Cancer, vol.58, pp.116-122, 1994.

J. Egginger and A. Calas, A novel hypothalamic neuroendocrine peptide: URP (urotensin-II-related peptide, C. R. Biol, vol.328, pp.724-731, 2005.

J. Egginger, A. Camus, and A. Calas, Urotensin-II expression in the mouse spinal cord, J. Chem. Neuroanat, vol.31, pp.146-154, 2006.

J. Egginger, C. Parmentier, G. Garrel, J. Cohen-tannoudji, A. Camus et al., Direct evidence for the co-expression of URP and GnRH in a sub-population of rat hypothalamic neurones: anatomical and functional correlation, Plos One, vol.6, p.26611, 2011.

S. Eguchi, K. Numaguchi, H. Iwasaki, T. Matsumoto, T. Yamakawa et al., Calciumdependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells, J. Biol. Chem, vol.273, pp.8890-8896, 1998.

M. Ehtesham, J. A. Winston, P. Kabos, and R. C. Thompson, CXCR4 expression mediates glioma cell invasiveness, Oncogene, vol.25, pp.2801-2806, 2006.

A. El-obeid, E. Bongcam-rudloff, M. Sörby, A. Ostman, M. Nistér et al., Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro, Cancer Res, vol.57, pp.5598-5604, 1997.

N. A. Elshourbagy, S. A. Douglas, U. Shabon, S. Harrison, G. Duddy et al., Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey, Br. J. Pharmacol, vol.136, pp.9-22, 2002.

R. Enz, The actin-binding protein Filamin-A interacts with the metabotropic glutamate receptor type 7, Febs Lett, vol.514, pp.184-188, 2002.

C. A. Erickson and J. P. Trinkaus, Microvilli and blebs as sources of reserve surface membrane during cell spreading, Exp. Cell Res, vol.99, pp.375-384, 1976.

O. P. Ernst, V. Gramse, M. Kolbe, K. P. Hofmann, and M. Heck, Monomeric G proteincoupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.10859-10864, 2007.

G. Esposito, C. Perrino, A. Cannavo, G. G. Schiattarella, F. Borgia et al., EGFR trans-activation by urotensin II receptor is mediated by ?-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy, Basic Res. Cardiol, vol.106, pp.577-589, 2011.

S. Etienne-manneville and A. Hall, Integrin-mediated activation of Cdc42 controls cell polarity in migrating astrocytes through PKCzeta, Cell, vol.106, pp.489-498, 2001.

S. Etienne-manneville and A. Hall, Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity, Nature, vol.421, pp.753-756, 2003.

S. Etienne-manneville, J. Manneville, S. Nicholls, M. A. Ferenczi, and A. Hall, Cdc42 and Par6-PKCzeta regulate the spatially localized association of Dlg1 and APC to control cell polarization, J. Cell Biol, vol.170, pp.895-901, 2005.

E. J. Ezratty, M. A. Partridge, and G. G. Gundersen, Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase, Nat. Cell Biol, vol.7, pp.581-590, 2005.

O. T. Fackler and R. Grosse, Cell motility through plasma membrane blebbing, J. Cell Biol, vol.181, pp.879-884, 2008.

E. M. Faller and D. L. Brown, Modulation of microtubule dynamics by the microtubuleassociated protein 1a, J. Neurosci. Res, vol.87, pp.1080-1089, 2009.

A. Farin, S. O. Suzuki, M. Weiker, J. E. Goldman, J. N. Bruce et al., Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis, Glia, vol.53, pp.799-808, 2006.

C. J. Farrell and S. R. Plotkin, Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes, Neurol. Clin, vol.25, pp.925-946, 2007.

C. Y. Fears, J. R. Grammer, J. E. Stewart, D. S. Annis, D. F. Mosher et al., Low-Density Lipoprotein Receptor-Related Protein Contributes to the Antiangiogenic Activity of Thrombospondin-2 in a Murine Glioma Model, Cancer Res, vol.65, pp.9338-9346, 2005.

A. J. Fegley, W. J. Tanski, E. Roztocil, and M. G. Davies, Sphingosine-1-phosphate stimulates smooth muscle cell migration through g?i-and pi3-kinase-dependent p38mapk activation, J. Surg. Res, vol.113, pp.32-41, 2003.

H. Feng, K. W. Liu, P. Guo, P. Zhang, T. Cheng et al., Dynamin 2 mediates PDGFR?-SHP-2-promoted glioblastoma growth and invasion, Oncogene, vol.31, pp.2691-2702, 2012.

I. Feoktistov, A. E. Goldstein, and I. Biaggioni, Cyclic AMP and protein kinase A stimulate Cdc42: role of A(2) adenosine receptors in human mast cells, Mol. Pharmacol, vol.58, pp.903-910, 2000.

S. Fernandez-sauze, C. Delfino, K. Mabrouk, C. Dussert, O. Chinot et al., Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: Involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors, Int. J. Cancer, vol.108, pp.797-804, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01823632

I. Fischer, J. Gagner, M. Law, E. W. Newcomb, and D. Zagzag, Angiogenesis in Gliomas: Biology and Molecular Pathophysiology, vol.15, pp.297-310, 2005.

J. L. Fisher, J. A. Schwartzbaum, M. Wrensch, and J. L. Wiemels, Epidemiology of brain tumors, Neurol. Clin, vol.25, pp.867-890, 2007.

A. M. Floden, S. Li, and C. K. Combs, Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.2566-2575, 2005.

S. Flohr, M. Kurz, E. Kostenis, A. Brkovich, A. Fournier et al., Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II, J. Med. Chem, vol.45, pp.1799-1805, 2002.

S. Foister, L. L. Taylor, J. Feng, W. Chen, A. Lin et al., Design and synthesis of potent cystine-free cyclic hexapeptide agonists at the human urotensin receptor, Org. Lett, vol.8, pp.1799-1802, 2006.

V. C. Foletta, M. A. Lim, J. Soosairajah, A. P. Kelly, E. G. Stanley et al., Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1, J. Cell Biol, vol.162, pp.1089-1098, 2003.

A. M. Fong, R. T. Premont, R. M. Richardson, Y. A. Yu, R. J. Lefkowitz et al., Defective lymphocyte chemotaxis in beta-arrestin2-and GRK6-deficient mice, Proc. Natl. Acad. Sci. U. S. A, vol.99, pp.7478-7483, 2002.

A. P. Fontes-sousa, C. Brás-silva, A. L. Pires, D. Monteiro-sousa, and A. F. Leite-moreira, Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling, Naunyn. Schmiedebergs Arch. Pharmacol, vol.376, pp.107-115, 2007.

F. Francke, F. Buck, and D. Bächner, MYND domain specific interaction of the melaninconcentrating hormone receptor 1 interacting zinc-finger protein with alpha-and beta-tubulin, Biochem. Biophys. Res. Commun, vol.334, pp.1292-1298, 2005.

S. J. Franco, M. A. Rodgers, B. J. Perrin, J. Han, D. A. Bennin et al., Calpain-mediated proteolysis of talin regulates adhesion dynamics, Nat. Cell Biol, vol.6, pp.977-983, 2004.

T. F. Franke, S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas et al., The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase, Cell, vol.81, pp.727-736, 1995.

C. Frantz, K. M. Stewart, and V. M. Weaver, The extracellular matrix at a glance, J. Cell Sci, vol.123, pp.4195-4200, 2010.

R. Fredriksson, M. C. Lagerström, L. Lundin, and H. B. Schiöth, The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints, Mol. Pharmacol, vol.63, pp.1256-1272, 2003.

P. Friedl and D. Gilmour, Collective cell migration in morphogenesis, regeneration and cancer, Nat. Rev. Mol. Cell Biol, vol.10, pp.445-457, 2009.

H. S. Friedman, T. Kerby, and H. Calvert, Temozolomide and treatment of malignant glioma, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.6, pp.2585-2597, 2000.

M. Fujita, N. M. Khazenzon, A. V. Ljubimov, B. Lee, I. Virtanen et al., Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis, Angiogenesis, vol.9, pp.183-191, 2006.

S. Fujiwara, K. Nakagawa, H. Harada, S. Nagato, K. Furukawa et al., Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas, Int. J. Oncol, vol.30, pp.793-802, 2007.

S. Fukushima, A. Yoshida, K. Honda, A. M. Maeshima, Y. Narita et al., Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation, Brain Tumor Pathol, 2013.

S. Funamoto, R. Meili, S. Lee, L. Parry, and R. A. Firtel, Spatial and Temporal Regulation of 3-Phosphoinositides by PI 3-Kinase and PTEN Mediates Chemotaxis, Cell, vol.109, pp.611-623, 2002.

F. B. Furnari, T. Fenton, R. M. Bachoo, A. Mukasa, J. M. Stommel et al., Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes Dev, vol.21, pp.2683-2710, 2007.

G. Gaidano, L. Bergui, M. Schena, M. Gaboli, O. Cremona et al., Integrin distribution and cytoskeleton organization in normal and malignant monocytes, Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund Uk, vol.4, pp.682-687, 1990.

E. Galanis, J. C. Buckner, M. J. Maurer, J. I. Kreisberg, K. Ballman et al., Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.23, pp.5294-5304, 2005.

S. Gao, Y. B. Oh, B. M. Park, W. H. Park, and S. H. Kim, Urotensin II protects ischemic reperfusion injury of hearts through ROS and antioxidant pathway, Peptides, vol.36, pp.199-205, 2012.

S. Gao, Y. Oh, A. Shah, W. H. Park, M. J. Chung et al., Urotensin II receptor antagonist attenuates monocrotaline-induced cardiac hypertrophy in rats, Am. J. Physiol. Heart Circ. Physiol, vol.299, pp.1782-1789, 2010.

M. L. Gardel, I. C. Schneider, ,. Aratyn-schaus, Y. Waterman, and C. M. , Mechanical Integration of Actin and Adhesion Dynamics in Cell Migration, Annu. Rev. Cell Dev. Biol, vol.26, pp.315-333, 2010.

S. M. Gardiner, J. E. March, P. A. Kemp, A. P. Davenport, and T. Bennett, Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats, Br. J. Pharmacol, vol.132, pp.1625-1629, 2001.

J. Gartlon, F. Parker, D. C. Harrison, S. A. Douglas, T. E. Ashmeade et al., Central effects of urotensin-II following ICV administration in rats, Psychopharmacology (Berl.), vol.155, pp.426-433, 2001.

L. Ge, S. K. Shenoy, R. J. Lefkowitz, and K. Defea, Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2, J. Biol. Chem, vol.279, pp.55419-55424, 2004.

G. Gendron, B. Simard, F. Gobeil, . Jr, P. Sirois et al., Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats, Can. J. Physiol. Pharmacol, vol.82, pp.16-21, 2004.

B. Geoerger, M. W. Kieran, S. Grupp, D. Perek, J. Clancy et al., Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma, Eur. J. Cancer Oxf. Engl, vol.48, pp.253-262, 1990.

H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist et al., VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J. Cell Biol, vol.161, pp.1163-1177, 2003.

G. Gerisch, B. Schroth-diez, A. Müller-taubenberger, and M. Ecke, Waves and PTEN Dynamics in the Emergence of Cell Polarity, Biophys. J, vol.103, pp.1170-1178, 2012.

A. Gibson, Complex effects of Gillichthys urotensin II on rat aortic strips, Br. J. Pharmacol, vol.91, pp.205-212, 1987.

A. Gibson, S. Conyers, and H. A. Bern, The influence of urotensin II on calcium flux in rat aorta, J. Pharm. Pharmacol, vol.40, pp.893-895, 1988.

G. Giebing, M. Tölle, J. Jürgensen, J. Eichhorst, J. Furkert et al., Arrestin-Independent Internalization and Recycling of the Urotensin Receptor Contribute to Long-Lasting Urotensin II-Mediated Vasoconstriction, Circ. Res, vol.97, pp.707-715, 2005.

A. Giese, R. Bjerkvig, M. E. Berens, and M. Westphal, Cost of migration: invasion of malignant gliomas and implications for treatment, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.21, pp.1624-1636, 2003.

L. Giuliani, L. Lenzini, M. Antonello, E. Aldighieri, A. S. Belloni et al., Expression and Functional Role of Urotensin-II and Its Receptor in the Adrenal Cortex and Medulla: Novel Insights for the Pathophysiology of Primary Aldosteronism, J. Clin. Endocrinol. Metab, vol.94, pp.684-690, 2009.

A. Glading, R. J. Bodnar, I. J. Reynolds, H. Shiraha, L. Satish et al., Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation, Mol. Cell. Biol, vol.24, pp.2499-2512, 2004.

C. L. Gladson and D. A. Cheresh, Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells, J. Clin. Invest, vol.88, pp.1924-1932, 1991.

A. M. Glodek, M. Honczarenko, Y. Le, J. J. Campbell, and L. E. Silberstein, Sustained Activation of Cell Adhesion Is a Differentially Regulated Process in B Lymphopoiesis, J. Exp. Med, vol.197, pp.461-473, 2003.

F. Gobeil, A. Fortier, T. Zhu, M. Bossolasco, M. Leduc et al., G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can, J. Physiol. Pharmacol, vol.84, pp.287-297, 2006.

J. W. Gober, M. R. Alley, and L. Shapiro, Positional information during Caulobacter cell differentiation, Curr. Opin. Genet. Dev, vol.1, pp.324-329, 1991.

N. Godessart and S. L. Kunkel, Chemokines in autoimmune disease, Curr. Opin. Immunol, vol.13, pp.670-675, 2001.

P. Goichberg, Y. Bai, D. D'amario, J. Ferreira-martins, C. Fiorini et al., The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction, Circ. Res, vol.108, pp.1071-1083, 2011.

C. K. Goldman, J. Kim, W. L. Wong, V. King, T. Brock et al., Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology, Mol. Biol. Cell, vol.4, pp.121-133, 1993.

C. Gomez-mouton, Dynamic redistribution of raft domains as an organizing platform for signaling during cell chemotaxis, J. Cell Biol, vol.164, pp.759-768, 2004.

C. S. Gondi, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati et al., Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth, Neuron Glia Biol, vol.1, pp.165-176, 2004.

C. S. Gondi, S. S. Lakka, N. Yanamandra, K. Siddique, D. H. Dinh et al., Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis, Oncogene, vol.22, pp.5967-5975, 2003.

H. Gong, Y. Wang, Y. Zhu, W. Wang, M. Wang et al., Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat, J. Appl. Physiol, vol.97, pp.2228-2235, 2004.

G. C. González, M. Martinez-padrón, K. Lederis, and K. Lukowiak, Distribution and coexistence of urotensin I and urotensin II peptides in the cerebral ganglia of Aplysia californica, Peptides, vol.13, pp.695-703, 1992.

E. G. Grau, R. S. Nishioka, and H. A. Bern, Effects of somatostatin and urotensin II on tilapia pituitary prolactin release and interactions between somatostatin, osmotic pressure Ca++, and adenosine 3',5'-monophosphate in prolactin release in vitro, Endocrinology, vol.110, pp.910-915, 1982.

P. Grieco, A. Carotenuto, P. Campiglia, E. Zampelli, R. Patacchini et al., A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge, J. Med. Chem, vol.45, pp.4391-4394, 2002.

P. Grieco, R. Franco, G. Bozzuto, L. Toccacieli, A. Sgambato et al., Urotensin II receptor predicts the clinical outcome of prostate cancer patients and is involved in the regulation of motility of prostate adenocarcinoma cells, J. Cell. Biochem, vol.112, pp.341-353, 2011.

N. A. Grieshaber, S. Boitano, I. Ji, J. P. Mather, J. et al., Differentiation of Granulosa Cell Line: Follicle-Stimulating Hormone Induces Formation of Lamellipodia and Filopodia via the Adenylyl Cyclase/Cyclic Adenosine Monophosphate Signal, Endocrinology, vol.141, pp.3461-3470, 2000.

A. G. Grieve, S. E. Moss, and M. J. Hayes, Annexin A2 at the interface of actin and membrane dynamics: a focus on its roles in endocytosis and cell polarization, Int. J. Cell Biol, p.852430, 2012.

P. G. Gritsenko, O. Ilina, and P. Friedl, Interstitial guidance of cancer invasion, J. Pathol, vol.226, pp.185-199, 2012.

M. D. Groves, V. K. Puduvalli, C. A. Conrad, M. R. Gilbert, W. K. Yung et al., Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status, J. Neurooncol, vol.80, pp.83-90, 2006.

M. D. Groves, V. K. Puduvalli, K. R. Hess, K. A. Jaeckle, P. Peterson et al., Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.20, pp.1383-1388, 2002.

W. Grüning, T. Arnould, F. Jochimsen, L. Sellin, S. Ananth et al., Modulation of renal tubular cell function by RGS3, Am. J. Physiol, vol.276, pp.535-543, 1999.

D. Gruson, A. Ginion, N. Decroly, P. Lause, J. L. Vanoverschelde et al., Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3beta signaling pathway, Peptides, vol.31, pp.1326-1333, 2010.

D. Gruson, M. F. Rousseau, S. A. Ahn, F. Van-linden, and J. M. Ketelslegers, Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers, Peptides, vol.27, pp.1527-1531, 2006.

A. Gschwind, N. Prenzel, and A. Ullrich, Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation, Cancer Res, vol.62, pp.6329-6336, 2002.

R. Guerrini, V. Camarda, E. Marzola, M. Arduin, G. Calo et al., Structure-activity relationship study on human urotensin II, J. Pept. Sci. Off. Publ. Eur. Pept. Soc, vol.11, pp.85-90, 2005.

D. Guidolin, G. Albertin, B. Oselladore, E. Sorato, P. Rebuffat et al., The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways, Regul. Pept, vol.162, pp.26-32, 2010.

P. Guo, B. Hu, W. Gu, L. Xu, D. Wang et al., Platelet-Derived Growth Factor-B Enhances Glioma Angiogenesis by Stimulating Vascular Endothelial Growth Factor Expression in Tumor Endothelia and by Promoting Pericyte Recruitment, Am. J. Pathol, vol.162, pp.1083-1093, 2003.

S. L. Gupton and C. M. Waterman-storer, Spatiotemporal Feedback between Actomyosin and Focal-Adhesion Systems Optimizes Rapid Cell Migration, Cell, vol.125, pp.1361-1374, 2006.

J. R. Guyon, E. Kudryashova, A. Potts, I. Dalkilic, M. A. Brosius et al., Calpain 3 cleaves filamin C and regulates its ability to interact with gamma-and delta-sarcoglycans, Muscle Nerve, vol.28, pp.472-483, 2003.

M. Hagel, E. L. George, A. Kim, R. Tamimi, S. L. Opitz et al., The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling, Mol. Cell. Biol, vol.22, pp.901-915, 2002.

C. Hagemann, J. Anacker, R. Ernestus, and G. H. Vince, A complete compilation of matrix metalloproteinase expression in human malignant gliomas, World J. Clin. Oncol, vol.3, pp.67-79, 2012.

B. Hallberg, S. I. Rayter, and J. Downward, Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation, J. Biol. Chem, vol.269, pp.3913-3916, 1994.

F. Hao, M. Tan, X. Xu, J. Han, D. D. Miller et al., Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA1, p42 and p38?, Biochim. Biophys. Acta Bba -Mol. Cell Biol. Lipids, vol.1771, pp.883-892, 2007.

L. Hardell, M. Carlberg, F. Söderqvist, K. H. Mild, and L. L. Morgan, Long-term use of cellular phones and brain tumours: increased risk associated with use for > or =10 years, Occup. Environ. Med, vol.64, pp.626-632, 2007.

M. J. Hart, X. Jiang, T. Kozasa, W. Roscoe, W. D. Singer et al., Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13, Science, vol.280, pp.2112-2114, 1998.

M. Hartlage-rübsamen, R. Lemke, and R. Schliebs, Interleukin-1beta, inducible nitric oxide synthase, and nuclear factor-kappaB are induced in morphologically distinct microglia after rat hippocampal lipopolysaccharide/interferon-gamma injection, J. Neurosci. Res, vol.57, pp.388-398, 1999.

G. S. Hassan, F. Chouiali, T. Saito, F. Hu, S. A. Douglas et al., Effect of human urotensin-II infusion on hemodynamics and cardiac function. Can, J. Physiol. Pharmacol, vol.81, pp.125-128, 2003.

G. S. Hassan, S. A. Douglas, E. H. Ohlstein, and A. Giaid, Expression of urotensin-II in human coronary atherosclerosis, Peptides, vol.26, pp.2464-2472, 2005.

J. M. Haugh, F. Codazzi, M. Teruel, and T. Meyer, Spatial sensing in fibroblasts mediated by 3' phosphoinositides, J. Cell Biol, vol.151, pp.1269-1280, 2000.

L. He, L. K. Pappan, D. G. Grenache, Z. Li, D. M. Tollefsen et al., The contributions of the alpha 2 beta 1 integrin to vascular thrombosis in vivo, Blood, vol.102, pp.3652-3657, 2003.

J. P. Heath and G. A. Dunn, Cell to substratum contacts of chick fibroblasts and their relation to the microfilament system. A correlated interference-reflexion and high-voltage electronmicroscope study, J. Cell Sci, vol.29, pp.197-212, 1978.

M. R. Heider and M. Munson, Exorcising the Exocyst Complex, Traffic, vol.13, pp.898-907, 2012.

J. Heller, M. Schepke, M. Neef, R. Woitas, C. Rabe et al., Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension, J. Hepatol, vol.37, pp.767-772, 2002.

P. K. Hepler, L. Vidali, and A. Y. Cheung, Polarized Cell Growth in Higher Plants, Annu. Rev. Cell Dev. Biol, vol.17, pp.159-187, 2001.

M. Heringlake, T. Kox, O. Uzun, B. Will, L. Bahlmann et al., The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease, Regul. Pept, vol.121, pp.129-136, 2004.

S. Hernandez-barrantes, M. Toth, M. M. Bernardo, M. Yurkova, D. C. Gervasi et al., Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation, J. Biol. Chem, vol.275, pp.12080-12089, 2000.

C. Herold-mende, M. M. Mueller, M. M. Bonsanto, H. P. Schmitt, S. Kunze et al., Clinical impact and functional aspects of tenascin-C expression during glioma progression, Int. J. Cancer J. Int. Cancer, vol.98, pp.362-369, 2002.

E. Hirata, Y. Arakawa, M. Shirahata, M. Yamaguchi, Y. Kishi et al., Endogenous tenascin-C enhances glioblastoma invasion with reactive change of surrounding brain tissue, Cancer Sci, vol.100, pp.1451-1459, 2009.

N. Hirokawa, Y. Noda, Y. Tanaka, and S. Niwa, Kinesin superfamily motor proteins and intracellular transport, Nat. Rev. Mol. Cell Biol, vol.10, pp.682-696, 2009.

T. Hirose, K. Takahashi, N. Mori, T. Nakayama, M. Kikuya et al., Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1. Peptides, vol.30, pp.1124-1129, 2009.

D. B. Hoelzinger, M. Nakada, T. Demuth, T. Rosensteel, L. B. Reavie et al., Autotaxin: a secreted autocrine/paracrine factor that promotes glioma invasion, J. Neurooncol, vol.86, pp.297-309, 2008.

M. J. Hogue, The effect of hypotonic and hypertonic solutions on fibroblasts of the embryonic chick heart in vitro, J. Exp. Med, vol.30, pp.617-648, 1919.

J. Holash, P. C. Maisonpierre, D. Compton, P. Boland, C. R. Alexander et al., Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, vol.284, 1994.

B. J. Holleran, I. Domazet, M. Beaulieu, L. P. Yan, G. Guillemette et al., Identification of transmembrane domain 6 and 7 residues that contribute to the binding pocket of the urotensin II receptor, Biochem. Pharmacol, vol.77, pp.1374-1382, 2009.

S. Holmin, T. Mathiesen, J. Shetye, and P. Biberfeld, Intracerebral inflammatory response to experimental brain contusion, Acta Neurochir, vol.132, pp.110-119, 1995.

J. Holtfreter, A study of the mechanics of gastrulation. Part I, J. Exp. Zool, vol.94, pp.261-318, 1943.

Z. Honda, M. Nakamura, I. Miki, M. Minami, T. Watanabe et al., Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung, Nature, vol.349, pp.342-346, 1991.

Z. Honda, T. Suzuki, and H. Honda, Identification of CENP-V as a novel microtubuleassociating molecule that activates Src family kinases through SH3 domain interaction, Genes Cells Devoted Mol. Cell. Mech, vol.14, pp.1383-1394, 2009.

X. Hong, F. Jiang, S. N. Kalkanis, Z. G. Zhang, X. Zhang et al., SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion, Cancer Lett, vol.236, pp.39-45, 2006.

Y. K. Hong, D. S. Chung, Y. A. Joe, Y. J. Yang, K. M. Kim et al., Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.6, pp.3354-3360, 2000.

N. A. Hotchin and A. Hall, The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases, J. Cell Biol, vol.131, pp.1857-1865, 1995.

C. Hsieh, P. Tsai, C. Tseng, Y. Chen, L. Chang et al., Inhibition of EGF/EGFR activation with naphtho[1,2-b]furan-4,5-dione blocks migration and invasion of MDA-MB-231 cells, Toxicol. In Vitro, vol.27, pp.1-10, 2013.

S. C. Hsu, O. V. Volpert, P. A. Steck, T. Mikkelsen, P. J. Polverini et al., Inhibition of Angiogenesis in Human Glioblastomas by Chromosome 10 Induction of Thrombospondin-1, Cancer Res, vol.56, pp.5684-5691, 1996.

R. Hu, G. Peng, H. Dai, E. Breuer, K. Stemke-hale et al., ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer, Cancer Res, vol.71, pp.6524-6534, 2011.

S. R. Hubbard and J. H. Till, Protein tyrosine kinase structure and function, Annu. Rev. Biochem, vol.69, pp.373-398, 2000.

S. Huitron-resendiz, M. P. Kristensen, M. Sánchez-alavez, S. D. Clark, S. L. Grupke et al., Urotensin II modulates rapid eye movement sleep through activation of brainstem cholinergic neurons, J. Neurosci. Off. J. Soc. Neurosci, vol.25, pp.5465-5474, 2005.

D. J. Hulmes, Building collagen molecules, fibrils, and suprafibrillar structures, J. Struct. Biol, vol.137, pp.2-10, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00313823

J. D. Humphries, P. Wang, C. Streuli, B. Geiger, M. J. Humphries et al., Vinculin controls focal adhesion formation by direct interactions with talin and actin, J. Cell Biol, vol.179, pp.1043-1057, 2007.

D. L. Hunton, W. G. Barnes, J. Kim, X. Ren, J. D. Violin et al., Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis, Mol. Pharmacol, vol.67, pp.1229-1236, 2005.

T. Ichikawa, K. Lederis, and H. Kobayashi, Primary structures of multiple forms of urotensin II in the urophysis of the carp, Cyprinus carpio, Gen. Comp. Endocrinol, vol.55, pp.133-141, 1984.

M. Iglewski and S. R. Grant, Urotensin II-induced signaling involved in proliferation of vascular smooth muscle cells, Vasc. Heal. Risk Manag, vol.6, pp.723-734, 2010.

T. Iguchi, K. Sakata, K. Yoshizaki, K. Tago, N. Mizuno et al., Orphan G proteincoupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway, J. Biol. Chem, vol.283, pp.14469-14478, 2008.

M. Iijima and P. Devreotes, Tumor suppressor PTEN mediates sensing of chemoattractant gradients, Cell, vol.109, pp.599-610, 2002.

A. Ishihata, T. Ogaki, T. Aita, and Y. Katano, Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats, Eur. J. Pharmacol, vol.523, pp.119-126, 2005.

H. Issafras, S. Angers, S. Bulenger, C. Blanpain, M. Parmentier et al., Constitutive agonist-independent CCR5 oligomerization and antibody-mediated clustering occurring at physiological levels of receptors, J. Biol. Chem, vol.277, pp.34666-34673, 2002.

H. Itoh, Y. Itoh, J. Rivier, and K. Lederis, Contraction of major artery segments of rat by fish neuropeptide urotensin II, Am. J. Physiol, vol.252, pp.361-366, 1987.

C. S. Izzard, A precursor of the focal contact in cultured fibroblasts, Cell Motil. Cytoskeleton, vol.10, pp.137-142, 1988.

C. S. Izzard and L. R. Lochner, Cell-to-substrate contacts in living fibroblasts: an interference reflexion study with an evaluation of the technique, J. Cell Sci, vol.21, pp.129-159, 1976.

H. S. Jang, S. Lal, and J. A. Greenwood, Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2, Neurochem. Res, vol.35, pp.1796-1804, 2010.

P. P. Jani, H. Narayan, and L. L. Ng, The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure, Peptides, vol.40, pp.72-76, 2012.

M. Jarry, M. Diallo, C. Lecointre, L. Desrues, T. Tokay et al., The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation, Biochem. J, vol.428, pp.113-124, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00479207

H. Järveläinen, A. Sainio, M. Koulu, T. N. Wight, and R. Penttinen, Extracellular matrix molecules: potential targets in pharmacotherapy, Pharmacol. Rev, vol.61, pp.198-223, 2009.

S. Jégou, D. Cartier, C. Dubessy, B. J. Gonzalez, D. Chatenet et al., Localization of the urotensin II receptor in the rat central nervous system, J. Comp. Neurol, vol.495, pp.21-36, 2006.

K. J. Jeong, S. Y. Park, J. H. Seo, K. B. Lee, W. S. Choi et al., Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells, Exp. Mol. Med, vol.40, pp.607-616, 2008.

X. Ji, G. Li, Y. Feng, J. Zhao, J. Li et al., EphB3 is overexpressed in non-small-cell lung cancer and promotes tumor metastasis by enhancing cell survival and migration, Cancer Res, vol.71, pp.1156-1166, 2011.

G. Jia, G. Cheng, D. M. Gangahar, and D. K. Agrawal, Involvement of connexin 43 in angiotensin II-induced migration and proliferation of saphenous vein smooth muscle cells via the MAPK-AP-1 signaling pathway, J. Mol. Cell. Cardiol, vol.44, pp.882-890, 2008.

G. Jiang, G. Giannone, D. R. Critchley, E. Fukumoto, and M. P. Sheetz, Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin, Nature, vol.424, pp.334-337, 2003.

S. Jiménez-baranda, C. Gómez-moutón, A. Rojas, L. Martínez-prats, E. Mira et al., Filamin-A regulates actin-dependent clustering of HIV receptors, Nat. Cell Biol, vol.9, pp.838-846, 2007.

M. C. Jiménez-sainz, C. Murga, A. Kavelaars, M. Jurado-pueyo, B. F. Krakstad et al., G protein-coupled receptor kinase 2 negatively regulates chemokine signaling at a level downstream from G protein subunits, Mol. Biol. Cell, vol.17, pp.25-31, 2006.

T. Jin, N. Zhang, Y. Long, C. A. Parent, and P. N. Devreotes, Localization of the G protein betagamma complex in living cells during chemotaxis, Science, vol.287, pp.1034-1036, 2000.

D. Joh, B. J. Park, and Y. J. Lim, Radiation-induced glioblastoma multiforme in a remitted acute lymphocytic leukemia patient, J. Korean Neurosurg. Soc, vol.50, pp.235-239, 2011.

D. G. Johns, Z. Ao, D. Naselsky, C. L. Herold, K. Maniscalco et al., Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators, Naunyn. Schmiedebergs Arch. Pharmacol, vol.370, pp.238-250, 2004.

D. Joyal, T. Huynh, N. Aiyar, B. Guida, S. Douglas et al., Urotensin-II levels in acute coronary syndromes, Int. J. Cardiol, vol.108, pp.31-35, 2006.

H. O. Jung, J. S. Uhm, S. M. Seo, J. H. Kim, H. Youn et al., Angiotensin II-induced smooth muscle cell migration is mediated by LDL receptor-related protein 1 via regulation of matrix metalloproteinase 2 expression, Biochem. Biophys. Res. Commun, vol.402, pp.577-582, 2010.

M. J. Jung, U. Murzik, L. Wehder, P. Hemmerich, and C. Melle, Regulation of cellular actin architecture by S100A10, Exp. Cell Res, vol.316, pp.1234-1240, 2010.

E. C. Kaal and C. J. Vecht, The management of brain edema in brain tumors, Curr. Opin. Oncol, vol.16, pp.593-600, 2004.

A. Kalmes, B. R. Vesti, G. Daum, J. A. Abraham, and A. W. Clowes, Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor, Circ. Res, vol.87, pp.92-98, 2000.

M. Kamiyama, A. Pozzi, L. Yang, L. M. Debusk, R. M. Breyer et al., EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival, Oncogene, vol.25, pp.7019-7028, 2006.

H. Kang, J. Ko, and S. Jang, The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells, Biochem. Biophys. Res. Commun, vol.423, pp.188-194, 2012.

H. R. Kaslow and D. L. Burns, Pertussis toxin and target eukaryotic cells: binding, entry, and activation, Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.6, pp.2684-2690, 1992.

G. Kassam, K. S. Choi, J. Ghuman, H. M. Kang, S. L. Fitzpatrick et al., The role of annexin II tetramer in the activation of plasminogen, J. Biol. Chem, vol.273, pp.4790-4799, 1998.

V. L. Katanaev, Signal transduction in neutrophil chemotaxis, Biochem. Biokhimii ? a, vol.66, pp.351-368, 2001.

Y. Katano, A. Ishihata, T. Aita, T. Ogaki, and T. Horie, Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries, Eur. J. Pharmacol, vol.402, pp.5-7, 2000.

B. Kaur, D. J. Brat, C. C. Calkins, and E. G. Van-meir, Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression, Am. J. Pathol, vol.162, pp.19-27, 2003.

B. Kaur, S. M. Cork, E. M. Sandberg, N. S. Devi, Z. Zhang et al., Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates In vivo Angiogenesis through a CD36-Dependent Mechanism, Cancer Res, vol.69, pp.1212-1220, 2009.

A. Kavelaars, A. Vroon, R. P. Raatgever, A. M. Fong, R. T. Premont et al., Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6, J. Immunol. Baltim. Md, vol.171, pp.6128-6134, 1950.

I. Kaverina, O. Krylyshkina, and J. V. Small, Microtubule Targeting of Substrate Contacts Promotes Their Relaxation and Dissociation, J. Cell Biol, vol.146, pp.1033-1044, 1999.

S. Kawa, S. Kimura, S. Hakomori, and Y. Igarashi, Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate, Febs Lett, vol.420, pp.196-200, 1997.

T. Kawata, T. Ishizuka, H. Tomura, T. Hisada, K. Dobashi et al., Sphingosine 1-phosphate inhibits migration and RANTES production in human bronchial smooth muscle cells, Biochem. Biophys. Res. Commun, vol.331, pp.640-647, 2005.

H. Keller and P. Eggli, Protrusive activity, cytoplasmic compartmentalization, and restriction rings in locomoting blebbing Walker carcinosarcoma cells are related to detachment of cortical actin from the plasma membrane, Cell Motil. Cytoskeleton, vol.41, pp.181-193, 1998.

H. U. Keller and H. Bebie, Protrusive activity quantitatively determines the rate and direction of cell locomotion, Cell Motil. Cytoskeleton, vol.33, pp.241-251, 1996.

P. Kelly, B. J. Moeller, J. Juneja, M. A. Booden, C. J. Der et al., The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.8173-8178, 2006.

P. Kelly, L. N. Stemmle, J. F. Madden, T. A. Fields, Y. Daaka et al., A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion, J. Biol. Chem, vol.281, pp.26483-26490, 2006.

C. J. Kelsall and R. J. Balment, Native urotensins influence cortisol secretion and plasma cortisol concentration in the euryhaline flounder, platichthys flesus, Gen. Comp. Endocrinol, vol.112, pp.210-219, 1998.

W. Kemp, H. Krum, J. Colman, M. Bailey, T. Yandle et al., Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension, Liver Int. Off. J. Int. Assoc. Study Liver, vol.27, pp.1232-1239, 2007.

S. Kenig, M. B. Alonso, M. M. Mueller, and T. T. Lah, Glioblastoma and endothelial cells cross-talk, mediated by SDF-1, enhances tumour invasion and endothelial proliferation by increasing expression of cathepsins B, S, and MMP-9, Cancer Lett, vol.289, pp.53-61, 2010.

A. V. Keymeulen, K. Wong, Z. A. Knight, C. Govaerts, K. M. Hahn et al., To stabilize neutrophil polarity, PIP3 and Cdc42 augment RhoA activity at the back as well as signals at the front, J. Cell Biol, vol.174, pp.437-445, 2006.

C. M. Kielty, M. J. Sherratt, and C. A. Shuttleworth, Elastic fibres, J. Cell Sci, vol.115, pp.2817-2828, 2002.

J. Kijowski, M. Baj-krzyworzeka, M. Majka, R. Reca, L. A. Marquez et al., The SDF-1-CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells, Stem Cells, vol.19, pp.453-466, 2001.

J. Kim, J. R. Keys, and A. D. Eckhart, Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq, Cell. Signal, vol.18, pp.1695-1701, 2006.

J. Kim, S. Jang, C. Kim, J. An, E. Kang et al., Tip60 regulates myoblast differentiation by enhancing the transcriptional activity of MyoD via their physical interactions, Febs J, vol.278, pp.4394-4404, 2011.

K. Kimura, M. Ito, M. Amano, K. Chihara, Y. Fukata et al., Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase), Science, vol.273, pp.245-248, 1996.

T. Kinashi, Intracellular signalling controlling integrin activation in lymphocytes, Nat. Rev. Immunol, vol.5, pp.546-559, 2005.

W. A. Kinney, H. R. Almond, J. Qi, C. E. Smith, R. J. Santulli et al., Structure-Function Analysis of Urotensin II and Its Use in the Construction of a Ligand-Receptor Working Model, Angew. Chem. Int. Ed, vol.41, pp.2940-2944, 2002.

W. B. Kiosses, S. J. Shattil, N. Pampori, and M. A. Schwartz, Rac recruits high-affinity integrin alphavbeta3 to lamellipodia in endothelial cell migration, Nat. Cell Biol, vol.3, pp.316-320, 2001.

Y. Kishi, S. Okudaira, M. Tanaka, K. Hama, D. Shida et al., Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid, J. Biol. Chem, vol.281, pp.17492-17500, 2006.

E. Kiyokawa, Y. Hashimoto, S. Kobayashi, H. Sugimura, T. Kurata et al., Activation of Rac1 by a Crk SH3-binding protein, DOCK180, Genes Dev, vol.12, pp.3331-3336, 1998.

R. Klein, Eph/ephrin signalling during development, Dev. Camb. Engl, vol.139, pp.4105-4109, 2012.

C. Kleinschnitz, M. Bendszus, M. Frank, L. Solymosi, K. V. Toyka et al., In Vivo Monitoring of Macrophage Infiltration in Experimental Ischemic Brain Lesions by Magnetic Resonance Imaging, J. Cereb. Blood Flow Metab, vol.23, pp.1356-1361, 2003.

R. L. Klemke, S. Cai, A. L. Giannini, P. J. Gallagher, P. De-lanerolle et al., Regulation of cell motility by mitogen-activated protein kinase, J. Cell Biol, vol.137, pp.481-492, 1997.

W. Kolch, Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions, Biochem. J, vol.351, issue.2, pp.289-305, 2000.

H. Komatani, Y. Sugita, F. Arakawa, K. Ohshima, and M. Shigemori, Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas, Int. J. Oncol, vol.34, pp.665-672, 2009.

A. R. Kompa, W. G. Thomas, F. See, A. Tzanidis, R. D. Hannan et al., Cardiovascular role of urotensin II: effect of chronic infusion in the rat, Peptides, vol.25, pp.1783-1788, 2004.

S. Koochekpour, M. Jeffers, S. Rulong, G. Taylor, E. Klineberg et al., Met and hepatocyte growth factor/scatter factor expression in human gliomas, Cancer Res, vol.57, pp.5391-5398, 1997.

S. Kosugi, M. Hasebe, M. Tomita, Y. , and H. , Systematic identification of cell cycledependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.10171-10176, 2009.

T. Kozasa, X. Jiang, M. J. Hart, P. M. Sternweis, W. D. Singer et al., RhoGEF, a GTPase activating protein for Galpha12 and Galpha13, vol.280, pp.2109-2111, 1998.

V. S. Kraynov, C. Chamberlain, G. M. Bokoch, M. A. Schwartz, S. Slabaugh et al., Localized Rac activation dynamics visualized in living cells, Science, vol.290, pp.333-337, 2000.

A. S. Kristof, Z. You, Y. Han, and A. Giaid, Protein expression of urotensin II, urotensinrelated peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis, Peptides, vol.31, pp.1511-1516, 2010.

H. Krum and W. Kemp, Therapeutic potential of blockade of the urotensin II system in systemic hypertension, Curr. Hypertens. Rep, vol.9, pp.53-58, 2007.

O. Krylyshkina, I. Kaverina, W. Kranewitter, W. Steffen, M. C. Alonso et al., Modulation of substrate adhesion dynamics via microtubule targeting requires kinesin-1, J. Cell Biol, vol.156, pp.349-360, 2002.

S. Kurosaka and A. Kashina, Cell Biology of Embryonic Migration, Birth Defects Res. Part C Embryo Today Rev, vol.84, pp.102-122, 2008.

A. J. Kuszak, S. Pitchiaya, J. P. Anand, H. I. Mosberg, N. G. Walter et al., Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2, J. Biol. Chem, vol.284, pp.26732-26741, 2009.

A. Kwiatkowska, M. Kijewska, M. Lipko, U. Hibner, and B. Kaminska, Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression, Biochim. Biophys. Acta, vol.1813, pp.655-667, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02193320

P. Labarrère, D. Chatenet, J. Leprince, C. Marionneau, G. Loirand et al., Structureactivity relationships of human urotensin II and related analogues on rat aortic ring contraction, J. Enzyme Inhib. Med. Chem, vol.18, pp.77-88, 2003.

Z. Lacza and D. Busija, Urotensin-II is a nitric oxide-dependent vasodilator in the pial arteries of the newborn pig, Life Sci, vol.78, pp.2763-2766, 2006.

F. P. Lai, M. Szczodrak, J. Block, J. Faix, D. Breitsprecher et al., Arp2/3 complex interactions and actin network turnover in lamellipodia, Embo J, vol.27, pp.982-992, 2008.

F. P. Lai, M. Szczodrak, J. M. Oelkers, M. Ladwein, F. Acconcia et al., Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases, Mol. Biol. Cell, vol.20, pp.3209-3223, 2009.

S. Lal, J. La-du, R. L. Tanguay, and J. A. Greenwood, Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment, J. Neurosci. Res, vol.90, pp.769-781, 2012.

K. Lamszus, U. Ulbricht, J. Matschke, M. A. Brockmann, R. Fillbrandt et al., Levels of Soluble Vascular Endothelial Growth Factor (VEGF) Receptor 1 in Astrocytic Tumors and Its Relation to Malignancy, Vascularity, and VEGF-A. Clin, Cancer Res, vol.9, pp.1399-1405, 2003.

F. Lancien, J. Leprince, N. Mimassi, D. Mabin, H. Vaudry et al., Central effects of native urotensin II on motor activity, ventilatory movements, and heart rate in the trout Oncorhynchus mykiss, Brain Res, vol.1023, pp.167-174, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01962791

R. G. Langham, D. J. Kelly, R. M. Gow, Y. Zhang, J. K. Dowling et al., Increased expression of urotensin II and urotensin II receptor in human diabetic nephropathy, Am. J. Kidney Dis, vol.44, pp.826-831, 2004.

H. Lapp, G. Boerrigter, L. C. Costello-boerrigter, K. Jaekel, T. Scheffold et al., Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy, Int. J. Cardiol, vol.94, pp.93-97, 2004.

L. I. Larsson, J. Fahrenkrug, O. S. Muckadell, F. Sundler, R. Håkanson et al., Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons, Proc. Natl. Acad. Sci. U. S. A, vol.73, p.3197, 1976.

L. T. Lau and A. C. Yu, Astrocytes produce and release interleukin-1, interleukin-6, tumor necrosis factor alpha and interferon-gamma following traumatic and metabolic injury, J. Neurotrauma, vol.18, pp.351-359, 2001.

D. A. Lauffenburger and A. F. Horwitz, Cell Migration: A Physically Integrated Molecular Process, Cell, vol.84, pp.359-369, 1996.

C. M. Laukaitis, D. J. Webb, K. Donais, and A. F. Horwitz, Differential Dynamics of ?5 Integrin, Paxillin, and ?-Actinin during Formation and Disassembly of Adhesions in Migrating Cells, J. Cell Biol, vol.153, pp.1427-1440, 2001.

C. Lawson, S. Lim, S. Uryu, X. L. Chen, D. A. Calderwood et al., FAK Promotes Recruitment of Talin to Nascent Adhesions to Control Cell Motility, J. Cell Biol, vol.196, pp.223-232, 2012.

L. J. Lawson, V. H. Perry, P. Dri, G. , and S. , Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain, Neuroscience, vol.39, pp.151-170, 1990.

D. M. Le, A. Besson, D. K. Fogg, K. Choi, D. M. Waisman et al., Exploitation of Astrocytes by Glioma Cells to Facilitate Invasiveness: A Mechanism Involving Matrix Metalloproteinase-2 and the Urokinase-Type Plasminogen Activator-Plasmin Cascade, J. Neurosci, vol.23, pp.4034-4043, 2003.

L. Mevel, J. C. Olson, K. R. Conklin, D. Waugh, D. Smith et al., Cardiovascular actions of trout urotensin II in the conscious trout, Oncorhynchus mykiss, Am. J. Physiol, vol.271, pp.1335-1343, 1996.

Y. Le, M. Honczarenko, A. M. Glodek, D. K. Ho, and L. E. Silberstein, CXC chemokine ligand 12-induced focal adhesion kinase activation and segregation into membrane domains is modulated by regulator of G protein signaling 1 in pro-B cells, J. Immunol. Baltim. Md, vol.174, pp.2582-2590, 1950.

D. K. Lee, A. J. Lança, R. Cheng, T. Nguyen, X. D. Ji et al., Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors, J. Biol. Chem, vol.279, pp.7901-7908, 2004.

H. J. Lee, M. Chun, and K. V. Kandror, Tip60 and HDAC7 interact with the endothelin receptor a and may be involved in downstream signaling, J. Biol. Chem, vol.276, pp.16597-16600, 2001.

S. T. Lee-hoeflich, C. G. Causing, M. Podkowa, X. Zhao, J. L. Wrana et al., Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis, Embo J, vol.23, pp.4792-4801, 2004.

J. Lee, A. Ishihara, G. Oxford, B. Johnson, and K. Jacobson, Regulation of cell movement is mediated by stretch-activated calcium channels, Nature, vol.400, pp.382-386, 1999.

S. Lee, J. Kunz, S. Lin, Y. , and L. , 16-kDa Prolactin Inhibits Endothelial Cell Migration by Down-Regulating the Ras-Tiam1-Rac1-Pak1 Signaling Pathway, Cancer Res, vol.67, pp.11045-11053, 2007.

W. J. Lee, J. S. Colt, E. F. Heineman, R. Mccomb, D. D. Weisenburger et al., Agricultural pesticide use and risk of glioma in Nebraska, United States, Occup. Environ. Med, vol.62, pp.786-792, 2005.

W. P. Leenders, B. Küsters, and R. M. De-waal, Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis, Endothel. J. Endothel. Cell Res, vol.9, pp.83-87, 2002.

K. R. Legate, S. A. Wickström, and R. Fässler, Genetic and cell biological analysis of integrin outside-in signaling, Genes Dev, vol.23, pp.397-418, 2009.

F. Lehmann, E. A. Currier, B. Clemons, L. K. Hansen, R. Olsson et al., Novel and potent small-molecule urotensin II receptor agonists, Bioorg. Med. Chem, vol.17, pp.4657-4665, 2009.

F. Lehmann, E. A. Currier, R. Olsson, U. Hacksell, and K. Luthman, Isochromanone-based urotensin-II receptor agonists, Bioorg. Med. Chem, vol.13, pp.3057-3068, 2005.

F. Lehmann, E. A. Currier, R. Olsson, J. Ma, E. S. Burstein et al., Optimization of isochromanone based urotensin II receptor agonists, Bioorg. Med. Chem, vol.18, pp.4844-4854, 2010.

F. Lehmann, L. Lake, E. A. Currier, R. Olsson, U. Hacksell et al., Design, parallel synthesis and SAR of novel urotensin II receptor agonists, Eur. J. Med. Chem, vol.42, pp.276-285, 2007.

F. Lehmann, A. Pettersen, E. A. Currier, V. Sherbukhin, R. Olsson et al., Novel potent and efficacious nonpeptidic urotensin II receptor agonists, J. Med. Chem, vol.49, pp.2232-2240, 2006.

U. Lehner, A. Veli?, R. Schroter, E. Schlatter, and A. Sindi?, Ligands and signaling of the G-protein-coupled receptor GPR14, expressed in human kidney cells, Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol, vol.20, pp.181-192, 2007.

A. D. Leonard, J. P. Thompson, E. L. Hutchinson, S. P. Young, J. Mcdonald et al., Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease, Br. J. Anaesth, vol.102, pp.477-484, 2009.

E. Lescot, J. Sopkova-de-oliveira-santos, N. Colloc'h, J. Rodrigo, I. Milazzo-segalas et al., Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model, Proteins, vol.73, pp.173-184, 2008.

E. Lescot, J. Sopkova-de-oliveira-santos, C. Dubessy, H. Oulyadi, A. Lesnard et al., Definition of new pharmacophores for nonpeptide antagonists of human urotensin-II. Comparison with the 3D-structure of human urotensin-II and URP, J. Chem. Inf. Model, vol.47, pp.602-612, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02179719

I. Letunic and P. Bork, Interactive Tree Of Life (iTOL): an online tool for phylogenetic tree display and annotation, Bioinforma. Oxf. Engl, vol.23, pp.127-128, 2007.

I. Letunic and P. Bork, Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy, Nucleic Acids Res, vol.39, pp.475-478, 2011.

N. Levicar, T. Strojnik, J. Kos, R. A. Dewey, G. J. Pilkington et al., Lysosomal enzymes, cathepsins in brain tumour invasion, J. Neurooncol, vol.58, pp.21-32, 2002.

A. Li, S. Dubey, M. L. Varney, B. J. Dave, and R. K. Singh, IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis, J. Immunol. Baltim. Md, vol.170, pp.3369-3376, 1950.

M. Li, J. C. Bermak, Z. W. Wang, and Q. Y. Zhou, Modulation of Dopamine D2 Receptor Signaling by Actin-Binding Protein (ABP-280), Mol. Pharmacol, vol.57, pp.446-452, 2000.

M. Li, C. Li, P. Weingarten, J. R. Bunzow, D. K. Grandy et al., Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280), Biochem. Pharmacol, vol.63, pp.859-863, 2002.

Z. Li, M. Hannigan, Z. Mo, B. Liu, W. Lu et al., Directional Sensing Requires G??-Mediated PAK1 and PIX?-Dependent Activation of Cdc42, Cell, vol.114, pp.215-227, 2003.

F. Liang, S. Lee, J. Liang, D. S. Lawrence, and Z. Zhang, The role of protein-tyrosine phosphatase 1B in integrin signaling, J. Biol. Chem, vol.280, pp.24857-24863, 2005.

H. Liao, M. C. Hyman, D. A. Lawrence, and D. J. Pinsky, Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha, Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.21, pp.935-949, 2007.

D. S. Lidke, K. A. Lidke, B. Rieger, T. M. Jovin, and D. J. Arndt-jovin, Reaching out for signals filopodia sense EGF and respond by directed retrograde transport of activated receptors, J. Cell Biol, vol.170, pp.619-626, 2005.

J. Liliental, S. Y. Moon, R. Lesche, R. Mamillapalli, D. Li et al., Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases, Curr. Biol. Cb, vol.10, pp.401-404, 2000.

L. H. Lim and S. Pervaiz, Annexin 1: the new face of an old molecule, Faseb J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.21, pp.968-975, 2007.

M. Lin, Y. Lu, H. Chen, C. Lee, J. Chung et al., Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by Curcumin inhibits SDF-1?-induced invasion of human esophageal carcinoma cells, Mol. Carcinog, 2012.

R. Lin, K. Karpa, N. Kabbani, P. Goldman-rakic, and R. Levenson, Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.5258-5263, 2001.

S. Lin, T. Y. Li, Q. Liu, C. Zhang, X. Li et al., GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy, Science, vol.336, pp.477-481, 2012.

Y. Lin, T. Tsuchihashi, K. Matsumura, I. Abe, and M. Iida, Central cardiovascular action of urotensin II in conscious rats, J. Hypertens, vol.21, pp.159-165, 2003.

Y. Lin, T. Tsuchihashi, K. Matsumura, M. Fukuhara, Y. Ohya et al., Central cardiovascular action of urotensin II in spontaneously hypertensive rats, Hypertens. Res. Off. J. Jpn. Soc. Hypertens, vol.26, pp.839-845, 2003.

S. Linder, The matrix corroded: podosomes and invadopodia in extracellular matrix degradation, Trends Cell Biol, vol.17, pp.107-117, 2007.

S. Linder, D. Nelson, M. Weiss, and M. Aepfelbacher, Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.9648-9653, 1999.

M. P. Little, P. Rajaraman, R. E. Curtis, S. S. Devesa, P. D. Inskip et al., Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States, BMJ, vol.344, p.1147, 2012.

D. Liu, J. Chen, J. Wang, Z. Zhang, X. Ma et al., Increased expression of urotensin II and GPR14 in patients with cirrhosis and portal hypertension, Int. J. Mol. Med, vol.25, pp.845-851, 2010.

J. Liu, C. Chen, J. Chen, and T. Cheng, Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor, Mol. Pharmacol, vol.76, pp.1186-1195, 2009.

Q. Liu, G. Li, R. Li, J. Shen, Q. He et al., IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines, J. Neurooncol, vol.100, pp.165-176, 2010.

Q. Liu, S. S. Pong, Z. Zeng, Q. Zhang, A. D. Howard et al., Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14, Biochem. Biophys. Res. Commun, vol.266, pp.174-178, 1999.

S. Liu, Q. Li, Q. Na, and C. Liu, Endothelin-1 stimulates human trophoblast cell migration through Cdc42 activation, Placenta, vol.33, pp.712-716, 2012.

B. H. Liwnicz, S. Z. Wu, and J. M. Tew, Jr (1987) The relationship between the capillary structure and hemorrhage in gliomas, J. Neurosurg, vol.66, pp.536-541

F. Lizárraga, R. Poincloux, M. Romao, G. Montagnac, G. Le-dez et al., Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells, Cancer Res, vol.69, pp.2792-2800, 2009.

D. Lli?, Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue et al., Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice, Publ. Online, 1995.

. Doi101038377539a0, , vol.377, pp.539-544

S. H. Lo, P. A. Janmey, J. H. Hartwig, and L. B. Chen, Interactions of tensin with actin and identification of its three distinct actin-binding domains, J. Cell Biol, vol.125, pp.1067-1075, 1994.

J. R. Lokensgard, S. Hu, W. Sheng, M. Vanoijen, D. Cox et al., Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus, J. Neurovirol, vol.7, pp.208-219, 2001.

D. N. Louis, H. Ohgaki, O. D. Wiestler, W. K. Cavenee, P. C. Burger et al., The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathol. (Berl.), vol.114, pp.97-109, 2007.

E. J. Lowenstein, R. J. Daly, A. G. Batzer, W. Li, B. Margolis et al., The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling, Cell, vol.70, pp.431-442, 1992.

C. J. Loy, K. S. Sim, Y. , and E. L. , Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.4562-4567, 2003.

D. Lu, Y. Leung, S. Huang, and K. Wong, Bradykinin-induced cell migration and COX-2 production mediated by the bradykinin B1 receptor in glioma cells, J. Cell. Biochem, vol.110, pp.141-150, 2010.

J. Lu, S. Moochhala, C. Kaur, and E. A. Ling, Cellular inflammatory response associated with breakdown of the blood-brain barrier after closed head injury in rats, J. Neurotrauma, vol.18, pp.399-408, 2001.

Y. Lu, C. Zou, D. Huang, and C. Tang, Cardiovascular effects of urotensin II in different brain areas, Peptides, vol.23, pp.1631-1635, 2002.

Z. Lu, G. Jiang, P. Blume-jensen, and T. Hunter, Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase, Mol. Cell. Biol, vol.21, pp.4016-4031, 2001.

J. M. Lundberg and K. Tatemoto, Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade, Acta Physiol. Scand, vol.116, pp.393-402, 1982.

A. D. Luster, R. Alon, and U. H. Von-andrian, Immune cell migration in inflammation: present and future therapeutic targets, Nat. Immunol, vol.6, pp.1182-1190, 2005.

L. M. Luttrell, G. J. Della-rocca, T. Van-biesen, D. K. Luttrell, and R. J. Lefkowitz, Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation, J. Biol. Chem, vol.272, pp.4637-4644, 1997.

C. Luxenburg, D. Geblinger, E. Klein, K. Anderson, D. Hanein et al., The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly, Plos One, vol.2, p.179, 2007.

C. D. Lynch, A. M. Lazar, T. Iskratsch, X. Zhang, and M. P. Sheetz, Endoplasmic spreading requires coalescence of vimentin intermediate filaments at force-bearing adhesions, Mol. Biol. Cell, vol.24, pp.21-30, 2012.

M. R. Maclean, D. Alexander, A. Stirrat, M. Gallagher, S. A. Douglas et al., Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat, Br. J. Pharmacol, vol.130, pp.201-204, 2000.

T. J. Macleod, M. Kwon, N. R. Filipenko, and D. M. Waisman, Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin, J. Biol. Chem, vol.278, pp.25577-25584, 2003.

J. R. Madden, S. O. Addo-yobo, A. M. Donson, A. K. Liu, S. A. Mcnatt et al., Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme, J. Pediatr. Hematol. Oncol, vol.32, pp.272-278, 2010.

P. A. Madureira, P. A. O'connell, A. P. Surette, V. A. Miller, and D. M. Waisman, The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis, J. Biomed. Biotechnol, p.353687, 2012.

R. D. Maestro, R. Shivers, W. Mcdonald, and A. D. Maestro, Dynamics of C6 astrocytoma invasion into three-dimensional collagen gels, J. Neurooncol, vol.53, pp.87-98, 2001.

N. Magnavita, R. A. Placentino, D. Mei, D. Ferraro, D. Trapani et al., Occupational head injury and subsequent glioma, Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol, vol.24, pp.31-33, 2003.

J. J. Maguire, R. E. Kuc, and A. P. Davenport, Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1, Br. J. Pharmacol, vol.131, pp.441-446, 2000.

J. J. Maguire, R. E. Kuc, M. J. Kleinz, and A. P. Davenport, Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: relevance to function, Peptides, vol.29, pp.735-742, 2008.

J. J. Maguire, R. E. Kuc, K. E. Wiley, M. J. Kleinz, and A. P. Davenport, Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries, Peptides, vol.25, pp.1767-1774, 2004.

E. A. Maher, C. Brennan, P. Y. Wen, L. Durso, K. L. Ligon et al., Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities, Cancer Res, vol.66, pp.11502-11513, 2006.

F. Mallamaci, S. Cutrupi, P. Pizzini, G. Tripepi, and C. Zoccali, Urotensin II in end-stage renal disease: an inverse correlate of sympathetic function and cardiac natriuretic peptides, J. Nephrol, vol.18, pp.727-732, 2005.

S. Mañes, R. A. Lacalle, C. Gómez-moutón, . Real, E. Mira et al., Membrane raft microdomains in chemokine receptor function, Semin. Immunol, vol.13, pp.147-157, 2001.

S. Mañes, E. Mira, C. Gómez-moutón, R. Ana-lacalle, P. Keller et al., Membrane raft microdomains mediate front-rear polarity in migrating cells, Embo J, vol.18, pp.6211-6220, 1999.

F. Manetti, LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators, Med. Res. Rev, vol.32, pp.968-998, 2012.

A. A. Mansour, O. Gafni, L. Weinberger, A. Zviran, M. Ayyash et al., The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming, Nature, vol.488, pp.409-413, 2012.

A. Marchese, M. Heiber, T. Nguyen, H. H. Heng, V. R. Saldivia et al., Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors, Genomics, vol.29, pp.335-344, 1995.

J. Marco, E. M. Egido, R. Hernández, and R. A. Silvestre, Evidence for endogenous urotensin-II as an inhibitor of insulin secretion. Study in the perfused rat pancreas, Peptides, vol.29, pp.852-858, 2008.

D. Maret, E. Gruzglin, M. S. Sadr, V. Siu, W. Shan et al., Surface Expression of Precursor N-cadherin Promotes Tumor Cell Invasion, Neoplasia New York N, vol.12, pp.1066-1080, 2010.

C. Margadant, H. N. Monsuur, J. C. Norman, and A. Sonnenberg, Mechanisms of integrin activation and trafficking, Curr. Opin. Cell Biol, vol.23, pp.607-614, 2011.

S. Marion, R. H. Oakley, K. Kim, M. G. Caron, and L. S. Barak, A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors, J. Biol. Chem, vol.281, pp.2932-2938, 2006.

D. S. Markovic, R. Glass, M. Synowitz, N. Rooijen, and H. Kettenmann, Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2, J. Neuropathol. Exp. Neurol, vol.64, pp.754-762, 2005.

D. S. Markovic, K. Vinnakota, S. Chirasani, M. Synowitz, H. Raguet et al., Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.12530-12535, 2009.

Y. Matsumoto, M. Abe, T. Watanabe, Y. Adachi, T. Yano et al., Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents, Neurosci. Lett, vol.358, pp.99-102, 2004.

A. Matsuno, H. Katayama, M. Murakami, and T. Nagashima, In vivo growth suppression of rat C6 glioma transplanted in rat brain using antisense oligonucleotide for microtubule-associated protein 1A messenger ribonucleic acid, Br. J. Neurosurg, vol.18, pp.343-346, 2004.

S. Matsusaka and I. Wakabayashi, Enhancement of vascular smooth muscle cell migration by urotensin II, Naunyn. Schmiedebergs Arch. Pharmacol, vol.373, pp.381-386, 2006.

M. Matsushita, M. Shichiri, N. Fukai, N. Ozawa, T. Yoshimoto et al., Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, vol.144, pp.1825-1831, 2003.

M. Matsushita, M. Shichiri, T. Imai, M. Iwashina, H. Tanaka et al., Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues, J. Hypertens, vol.19, pp.2185-2190, 2001.

F. Mccormick, Signal transduction. How receptors turn Ras on, Nature, vol.363, pp.15-16, 1993.

R. G. Mcfadden and K. E. Vickers, Bradykinin augments the in vitro migration of nonsensitized lymphocytes, Clin. Investig. Med. Médecine Clin. Exp, vol.12, pp.247-253, 1989.

B. P. Mckinley, A. M. Michalek, R. A. Fenstermaker, and R. J. Plunkett, The impact of age and sex on the incidence of glial tumors in New York state from 1976 to 1995, J. Neurosurg, vol.93, pp.932-939, 2000.

D. Mcmaster, M. A. Belenky, A. L. Polenov, and K. Lederis, Isolation and amino acid sequence of urotensin II from the sturgeon Acipenser ruthenus, Gen. Comp. Endocrinol, vol.87, pp.275-285, 1992.

D. Mcmaster and K. Lederis, Isolation and amino acid sequence of two urotensin II peptides from Catostomus commersoni urophyses, Peptides, vol.4, pp.367-373, 1983.

P. J. Medeiros, B. K. Al-khazraji, N. M. Novielli, L. M. Postovit, A. F. Chambers et al., Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line, Int. J. Cancer J. Int. Cancer, vol.131, pp.276-286, 2012.

R. Meili, C. Ellsworth, S. Lee, T. B. Reddy, H. Ma et al., Chemoattractantmediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium, Embo J, vol.18, pp.2092-2105, 1999.

R. Meili and R. A. Firtel, Two Poles and a Compass, Cell, vol.114, pp.153-156, 2003.

J. Meisenhelder, P. G. Suh, S. G. Rhee, and T. Hunter, Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro, Cell, vol.57, pp.1109-1122, 1989.

R. Mentlein and J. Held-feindt, Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas, J. Neurochem, vol.83, pp.747-753, 2002.

E. M. Metchnikoff, Immunity in Infective Diseases, 1905.

K. S. Midwood, L. V. Williams, and J. E. Schwarzbauer, Tissue repair and the dynamics of the extracellular matrix, Int. J. Biochem. Cell Biol, vol.36, pp.1031-1037, 2004.

M. Mifune, H. Ohtsu, H. Suzuki, H. Nakashima, E. Brailoiu et al., ) G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor, J. Biol. Chem, vol.280, pp.26592-26599, 2005.

H. Miki, S. Suetsugu, and T. Takenawa, WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac, Embo J, vol.17, pp.6932-6941, 1998.

A. Minagar and J. S. Alexander, Blood-brain barrier disruption in multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.9, pp.540-549, 2003.

L. Minsaas, J. Planagumà, M. Madziva, B. F. Krakstad, M. Masià-balagué et al., Filamin A Binds to CCR2B and Regulates Its Internalization, Plos One, vol.5, p.12212, 2010.

S. K. Mitra, D. A. Hanson, and D. D. Schlaepfer, Focal adhesion kinase: in command and control of cell motility, Nat. Rev. Mol. Cell Biol, vol.6, pp.56-68, 2005.

N. Miyake, S. Mizuno, N. Okamoto, H. Ohashi, M. Shiina et al., KDM6A point mutations cause Kabuki syndrome, Hum. Mutat, vol.34, pp.108-110, 2013.

N. Mizuno, H. Kokubu, M. Sato, A. Nishimura, J. Yamauchi et al., G protein-coupled receptor signaling through Gq and JNK negatively regulates neural progenitor cell migration, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.12365-12370, 2005.

S. J. Monkley, X. H. Zhou, S. J. Kinston, S. M. Giblett, L. Hemmings et al., Disruption of the talin gene arrests mouse development at the gastrulation stage, Dev. Dyn. Off. Publ. Am. Assoc. Anat, vol.219, pp.560-574, 2000.

W. L. Monsky, C. Lin, A. Aoyama, T. Kelly, S. K. Akiyama et al., A Potential Marker Protease of Invasiveness, Separase, Is Localized on Invadopodia of Human Malignant Melanoma Cells, Cancer Res, vol.54, pp.5702-5710, 1994.

V. Montana and H. Sontheimer, Bradykinin promotes the chemotactic invasion of primary brain tumors, J. Neurosci. Off. J. Soc. Neurosci, vol.31, pp.4858-4867, 2011.

M. Monterrubio, M. Mellado, A. C. Carrera, and J. M. Rodríguez-frade, PI3Kgamma activation by CXCL12 regulates tumor cell adhesion and invasion, Biochem. Biophys. Res. Commun, vol.388, pp.199-204, 2009.

V. Moreau, F. Tatin, C. Varon, and E. Génot, Actin can reorganize into podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA, Mol. Cell. Biol, vol.23, pp.6809-6822, 2003.

M. R. Morgan, M. J. Humphries, and M. D. Bass, Synergistic control of cell adhesion by integrins and syndecans, Nat. Rev. Mol. Cell Biol, vol.8, pp.957-969, 2007.

M. Mori, T. Sugo, M. Abe, Y. Shimomura, M. Kurihara et al., Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14), Biochem. Biophys. Res. Commun, vol.265, pp.123-129, 1999.

N. Mori, T. Hirose, T. Nakayama, O. Ito, M. Kanazawa et al., Increased expression of urotensin II-related peptide and its receptor in kidney with hypertension or renal failure, Peptides, vol.30, pp.400-408, 2009.

R. Morimoto, F. Satoh, O. Murakami, K. Totsune, Y. Arai et al., Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues, Peptides, vol.29, pp.873-880, 2008.

B. Mosch, B. Reissenweber, C. Neuber, and J. Pietzsch, Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis, J. Oncol, pp.1-12, 2010.

B. E. Mugabe, F. A. Yaghini, C. Y. Song, C. K. Buharalioglu, C. M. Waters et al., Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogenactivated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation, J. Pharmacol. Exp. Ther, vol.332, pp.116-124, 2010.

O. Muriel, A. Echarri, C. Hellriegel, D. M. Pavón, L. Beccari et al., Phosphorylated filamin A regulates actin-linked caveolae dynamics, J. Cell Sci, vol.124, pp.2763-2776, 2011.

P. M. Murphy, M. Baggiolini, I. F. Charo, C. A. Hébert, R. Horuk et al., International union of pharmacology. XXII. Nomenclature for chemokine receptors, Pharmacol. Rev, vol.52, pp.145-176, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00399158

N. Prasad, S. V. Barak, L. S. Rapacciuolo, A. Caron, M. G. Rockman et al., Agonistdependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration, J. Biol. Chem, vol.276, pp.18953-18959, 2001.

N. Prasad, S. V. Jayatilleke, A. Madamanchi, A. Rockman, and H. A. , Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis, Nat. Cell Biol, vol.7, pp.785-796, 2005.

M. Nagano, D. Hoshino, N. Koshikawa, T. Akizawa, and M. Seiki, Turnover of Focal Adhesions and Cancer Cell Migration, Int. J. Cell Biol, pp.1-10, 2012.

N. Nagano, H. Sasaki, M. Aoyagi, and K. Hirakawa, Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells, Acta Neuropathol. (Berl.), vol.86, pp.117-125, 1993.

S. Najib, N. Saint-laurent, J. Esteve, S. Schulz, E. Boutet-robinet et al., A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)-p85 to Filamin A Negatively Controls the PI3K Pathway, Mol. Cell. Biol, vol.32, pp.1004-1016, 2012.

M. Nakada, S. Nakada, T. Demuth, N. L. Tran, D. B. Hoelzinger et al., Molecular targets of glioma invasion, Cell. Mol. Life Sci. Cmls, vol.64, pp.458-478, 2007.

F. Nakamura, T. P. Stossel, and J. H. Hartwig, The filamins: organizers of cell structure and function, Cell Adhes. Migr, vol.5, pp.160-169, 2011.

T. Nakayama, T. Hirose, K. Totsune, N. Mori, Y. Maruyama et al., Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure, Peptides, vol.29, pp.801-808, 2008.

A. Nayal, D. J. Webb, C. M. Brown, E. M. Schaefer, M. Vicente-manzanares et al., Paxillin phosphorylation at Ser273 localizes a GIT1-PIX-PAK complex and regulates adhesion and protrusion dynamics, J. Cell Biol, vol.173, pp.587-589, 2006.

E. J. Neer and D. E. Clapham, Roles of G protein subunits in transmembrane signalling, Nature, vol.333, pp.129-134, 1988.

G. Neufeld, A. D. Sabag, N. Rabinovicz, and O. Kessler, Semaphorins in Angiogenesis and Tumor Progression. Cold Spring Harb, Perspect. Med, vol.2, 2012.

S. R. Neves, P. T. Ram, and R. Iyengar, Protein Pathways. Science, vol.296, pp.1636-1639, 2002.

L. L. Ng, I. Loke, R. J. O'brien, I. B. Squire, and J. E. Davies, Plasma urotensin in human systolic heart failure, Circulation, vol.106, pp.2877-2880, 2002.

T. M. Nguyen, M. Létourneau, D. Chatenet, and A. Fournier, Presence of urotensin-II receptors at the cell nucleus: Specific tissue distribution and hypoxia-induced modulation, Int. J. Biochem. Cell Biol, vol.44, pp.639-647, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-00817600

M. Nieto, J. M. Frade, D. Sancho, M. Mellado, C. Martinez-a et al., Polarization of Chemokine Receptors to the Leading Edge during Lymphocyte Chemotaxis, J. Exp. Med, vol.186, pp.153-158, 1997.

A. Nimmerjahn, F. Kirchhoff, and F. Helmchen, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, vol.308, pp.1314-1318, 2005.

K. Nishikawa, K. Ayukawa, Y. Hara, K. Wada, and S. Aoki, Endothelin/endothelin-B receptor signals regulate ventricle-directed interkinetic nuclear migration of cerebral cortical neural progenitors, Neurochem. Int, vol.58, pp.261-272, 2011.

M. Nissou, M. El-atifi, A. Guttin, C. Godfraind, C. Salon et al., Hypoxia-induced expression of VE-cadherin and filamin B in glioma cell cultures and pseudopalisade structures, J. Neurooncol, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00851136

G. Niu, Why Integrin as a Primary Target for Imaging and Therapy. Theranostics, p.30, 2011.

S. Nobata, J. A. Donald, R. J. Balment, and Y. Takei, Potent cardiovascular effects of homologous urotensin II (UII)-related peptide and UII in unanesthetized eels after peripheral and central injections, Am. J. Physiol. Regul. Integr. Comp. Physiol, vol.300, pp.437-446, 2011.

C. D. Nobes and A. Hall, Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia, Cell, vol.81, pp.53-62, 1995.

R. Noiges, R. Eichinger, W. Kutschera, I. Fischer, Z. Nemeth et al., Microtubule-associated protein 1A (MAP1A) and MAP1B: light chains determine distinct functional properties, J. Neurosci. Off. J. Soc. Neurosci, vol.22, pp.2106-2114, 2002.

S. Nomura, H. Yoshitomi, S. Takano, T. Shida, S. Kobayashi et al., FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer, Br. J. Cancer, vol.99, pp.305-313, 2008.

A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas et al., Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence, Neurology, vol.70, pp.779-787, 2008.

H. P. Nothacker, Z. Wang, A. M. Mcneill, Y. Saito, S. Merten et al., Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction, Nat. Cell Biol, vol.1, pp.383-385, 1999.

H. P. Nothacker, Z. Wang, A. M. Mcneill, Y. Saito, S. Merten et al., Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction, Nat. Cell Biol, vol.1, pp.383-385, 1999.

M. P. O'connell, J. L. Fiori, K. M. Baugher, F. E. Indig, A. D. French et al., Wnt5A activates the calpain-mediated cleavage of filamin A, J. Invest. Dermatol, vol.129, pp.1782-1789, 2009.

P. Oh and J. E. Schnitzer, Segregation of Heterotrimeric G Proteins in Cell Surface Microdomains Gq Binds Caveolin to Concentrate in Caveolae, whereas Gi and Gs Target Lipid Rafts by Default, Mol. Biol. Cell, vol.12, pp.685-698, 2001.

Y. Ohta, N. Suzuki, S. Nakamura, J. H. Hartwig, and T. P. Stossel, The small GTPase RalA targets filamin to induce filopodia, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.2122-2128, 1999.

M. Okada, M. Saio, Y. Kito, N. Ohe, H. Yano et al., Tumor-associated macrophage/microglia infiltration in human gliomas is correlated with MCP-3, but not MCP-1, Int. J. Oncol, vol.34, pp.1621-1627, 2009.

H. Okamoto, Y. Yatomi, T. Ohmori, K. Satoh, Y. Matsumoto et al., Sphingosine 1-Phosphate Stimulates Gi-and Rho-Mediated Vascular Endothelial Cell Spreading and Migration, Thromb. Res, vol.99, pp.259-265, 2000.

I. Okamoto, Y. Kawano, H. Tsuiki, J. Sasaki, M. Nakao et al., CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration, Oncogene, vol.18, pp.1435-1446, 1999.

S. Okumus, Y. Z. Igci, T. Taskin, S. Oztuzcu, B. Gurler et al., Association between Thr21Met and Ser89Asn polymorphisms of the urotensin-II (UTS2) gene, diabetes mellitus, and diabetic retinopathy, Curr. Eye Res, vol.37, pp.921-929, 2012.

J. V. Olsen, B. Blagoev, F. Gnad, B. Macek, C. Kumar et al., ) Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks, Cell, vol.127, pp.635-648, 2006.

J. V. Olsen, M. Vermeulen, A. Santamaria, C. Kumar, M. L. Miller et al., Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis, Sci. Signal, vol.3, p.3, 2010.

D. Onan, L. Pipolo, E. Yang, R. D. Hannan, and W. G. Thomas, Urotensin II Promotes Hypertrophy of Cardiac Myocytes via Mitogen-Activated Protein Kinases, Mol. Endocrinol, vol.18, pp.2344-2354, 2004.

A. M. Onat, Y. Pehlivan, I. H. Turkbeyler, T. Demir, D. S. Kaplan et al., Urotensin Inhibition with Palosuran Could Be a Promising Alternative in Pulmonary Arterial Hypertension, 2012.

A. M. Onat, I. H. Turkbeyler, Y. Pehlivan, T. Demir, D. S. Kaplan et al., The efficiency of a urotensin II antagonist in an experimental lung fibrosis model, Inflammation, vol.35, pp.1138-1143, 2012.

K. L. Ong, L. Y. Wong, Y. B. Man, R. Y. Leung, Y. Song et al., Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance, Peptides, vol.27, pp.1659-1667, 2006.

T. Ono, Y. Kawaguchi, M. Kudo, T. Kushikata, E. Hashiba et al., Urotensin II evokes neurotransmitter release from rat cerebrocortical slices, Neurosci. Lett, vol.440, pp.275-279, 2008.

I. Onoprishvili, M. L. Andria, H. K. Kramer, N. Ancevska-taneva, J. M. Hiller et al., Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking, Mol. Pharmacol, vol.64, pp.1092-1100, 2003.

O. S. Opgaard, H. Nothacker, F. J. Ehlert, and D. N. Krause, Human urotensin II mediates vasoconstriction via an increase in inositol phosphates, Eur. J. Pharmacol, vol.406, pp.265-271, 2000.

C. A. Otey, F. M. Pavalko, and K. Burridge, An interaction between alpha-actinin and the beta 1 integrin subunit in vitro, J. Cell Biol, vol.111, pp.721-729, 1990.

G. C. Owens, E. A. Orr, B. K. Demasters, R. J. Muschel, M. E. Berens et al., Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma, Cancer Res, vol.58, pp.2020-2028, 1998.

T. P. Padera, B. R. Stoll, J. B. Tooredman, D. Capen, E. Di-tomaso et al., Pathology: cancer cells compress intratumour vessels, Nature, vol.427, p.695, 2004.

I. Paegelow and P. Lange, Pharmacological studies on lymphocytes. 1. Effects of 5-hydroxytryptamine, bradykinin, and lymphokines on the migration of lymphocytes in vitro, Agents Actions. Suppl, vol.10, pp.255-265, 1982.

R. Pakala, Role of urotensin II in atherosclerotic cardiovascular diseases, Cardiovasc. Revascularization Med. Mol. Interv, vol.9, pp.166-178, 2008.

S. P. Palecek, C. E. Schmidt, D. A. Lauffenburger, and A. F. Horwitz, Integrin dynamics on the tail region of migrating fibroblasts, J. Cell Sci, vol.109, pp.941-952, 1996.

J. Pan, J. Mestas, M. D. Burdick, R. J. Phillips, G. V. Thomas et al., Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis, Mol. Cancer, vol.5, p.56, 2006.

T. S. Panetti, J. Nowlen, and D. F. Mosher, Sphingosine-1-Phosphate and Lysophosphatidic Acid Stimulate Endothelial Cell Migration, Arterioscler. Thromb. Vasc. Biol, vol.20, pp.1013-1019, 2000.

R. Pankov, E. Cukierman, B. Katz, K. Matsumoto, D. C. Lin et al., Integrin Dynamics and Matrix Assembly Tensin-Dependent Translocation of ?5?1 Integrins Promotes Early Fibronectin Fibrillogenesis, J. Cell Biol, vol.148, pp.1075-1090, 2000.

A. Papapetropoulos, G. García-cardeña, T. J. Dengler, P. C. Maisonpierre, G. D. Yancopoulos et al., Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors, Lab. Investig. J. Tech. Methods Pathol, vol.79, pp.213-223, 1999.

C. A. Parent and P. N. Devreotes, A cell's sense of direction, Science, vol.284, pp.765-770, 1999.

C. Parmentier, E. Hameury, C. Dubessy, F. B. Quan, D. Habert et al., Occurrence of two distinct urotensin II-related peptides in zebrafish provides new insight into the evolutionary history of the urotensin II gene family, Endocrinology, vol.152, pp.2330-2341, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02179710

C. Parmentier, E. Hameury, I. Lihrmann, J. Taxi, H. Hardin-pouzet et al., Comparative distribution of the mRNAs encoding urotensin I and urotensin II in zebrafish, Peptides, vol.29, pp.820-829, 2008.

J. T. Parsons, A. R. Horwitz, and M. A. Schwartz, Cell adhesion: integrating cytoskeletal dynamics and cellular tension, Nat. Rev. Mol. Cell Biol, vol.11, pp.633-643, 2010.

M. Parsons, J. Monypenny, S. M. Ameer-beg, T. H. Millard, L. M. Machesky et al., Spatially distinct binding of Cdc42 to PAK1 and N-WASP in breast carcinoma cells, Mol. Cell. Biol, vol.25, pp.1680-1695, 2005.

R. Patacchini, P. Santicioli, S. Giuliani, P. Grieco, E. Novellino et al., Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta, Br. J. Pharmacol, vol.140, pp.1155-1158, 2003.

J. H. Patel, Y. Du, P. G. Ard, C. Phillips, B. Carella et al., The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60, Mol. Cell. Biol, vol.24, pp.10826-10834, 2004.

W. Paulus, I. Baur, A. S. Beutler, and S. A. Reeves, Diffuse brain invasion of glioma cells requires beta 1 integrins, Lab. Investig. J. Tech. Methods Pathol, vol.75, pp.819-826, 1996.

R. Pawar, W. Kemp, S. Roberts, H. Krum, T. Yandle et al., Urotensin II levels are an important marker for the severity of portal hypertension in children, J. Pediatr. Gastroenterol. Nutr, vol.53, pp.88-92, 2011.

L. Pa?anin, M. Vu?i?, H. ?upi?, D. Plavec, and B. Kru?lin, IGFBP-2 expression, angiogenesis and pseudopalisades in glioblastoma, Transl. Neurosci, vol.2, pp.219-224, 2011.

D. Pearson, J. E. Shively, B. R. Clark, I. I. Geschwind, M. Barkley et al., Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes, Proc. Natl. Acad. Sci. U. S. A, vol.77, pp.5021-5024, 1980.

G. Pelletier, I. Lihrmann, C. Dubessy, V. Luu-the, H. Vaudry et al., Androgenic down-regulation of urotensin II precursor, urotensin II-related peptide precursor and androgen receptor mRNA in the mouse spinal cord, Neuroscience, vol.132, pp.689-696, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02179722

G. Pelletier, I. Lihrmann, and H. Vaudry, Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord, Neuroscience, vol.115, pp.525-532, 2002.

W. Penfield, Microglia and the Process of Phagocytosis in Gliomas, Am. J. Pathol, vol.1, pp.77-90, 1925.

Y. Percherancier, Y. A. Berchiche, I. Slight, R. Volkmer-engert, H. Tamamura et al., Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo-and heterodimers, J. Biol. Chem, vol.280, pp.9895-9903, 2005.

C. Perego, C. Vanoni, S. Massari, A. Raimondi, S. Pola et al., Invasive behaviour of glioblastoma cell lines is associated with altered organisation of the cadherin-catenin adhesion system, J. Cell Sci, vol.115, pp.3331-3340, 2002.

T. D. Perkins, S. Bansal, and D. J. Barlow, Molecular modelling and design of analogues of the peptide hormone urotensin II, Biochem. Soc. Trans, vol.18, pp.918-919, 1990.

M. Perret, H. Broussard, T. Legros, A. Burns, J. K. Chang et al., The effect of adrenomedullin on the isolated heart, Life Sci, vol.53, pp.377-379, 1993.

O. Pertz, L. Hodgson, R. L. Klemke, and K. M. Hahn, Spatiotemporal dynamics of RhoA activity in migrating cells, Nature, vol.440, pp.1069-1072, 2006.

R. J. Phillips, M. D. Burdick, M. Lutz, J. A. Belperio, M. P. Keane et al., The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases, Am. J. Respir. Crit. Care Med, vol.167, pp.1676-1686, 2003.

C. S. Pichot, C. Arvanitis, S. M. Hartig, S. A. Jensen, J. Bechill et al., Cdc42-Interacting Protein 4 Promotes Breast Cancer Cell Invasion and Formation of Invadopodia Through Activation of N-WASp, Cancer Res, vol.70, pp.8347-8356, 2010.

K. L. Pierce, A. Tohgo, S. Ahn, M. E. Field, L. M. Luttrell et al., Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a coculture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding, J. Biol. Chem, vol.276, pp.23155-23160, 2001.

J. Planagumà, L. Minsaas, M. Pons, L. Myhren, G. Garrido et al., Filamin A-Hinge Region 1-EGFP: A Novel Tool for Tracking the Cellular Functions of Filamin A in Real-Time, Plos One, vol.7, p.40864, 2012.

K. H. Plate, G. Breier, H. A. Weich, H. D. Mennel, and W. Risau, Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms, Int. J. Cancer, vol.59, pp.520-529, 1994.

K. H. Plate, G. Breier, H. A. Weich, and W. Risau, Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo, Nature, vol.359, pp.845-848, 1992.

M. Platten, A. Kretz, U. Naumann, S. Aulwurm, K. Egashira et al., Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas, Ann. Neurol, vol.54, pp.388-392, 2003.

M. Platten, W. Wick, and M. Weller, Malignant glioma biology: Role for TGF-? in growth, motility, angiogenesis, and immune escape, Microsc. Res. Tech, vol.52, pp.401-410, 2001.

M. Pluderi, V. Lucini, D. Caronzolo, M. Pannacci, F. Costa et al., Long-term inhibition of glioma growth by systemic administration of human PEX, J. Neurosurg. Sci, vol.47, pp.69-78, 2003.

R. J. Plunkett, A. Lis, T. A. Barone, M. D. Fronckowiak, and S. J. Greenberg, Hormonal effects on glioblastoma multiforme in the nude rat model, J. Neurosurg, vol.90, pp.1072-1077, 1999.

M. D. Prados, Future directions in the treatment of malignant gliomas with temozolomide, Semin. Oncol, vol.27, pp.41-46, 2000.

E. Prat, P. Baron, L. Meda, E. Scarpini, D. Galimberti et al., The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein, Neurosci. Lett, vol.283, pp.177-180, 2000.

N. Prenzel, E. Zwick, H. Daub, M. Leserer, R. Abraham et al., EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF, Nature, vol.402, pp.884-888, 1999.

H. C. Prosser, J. Leprince, H. Vaudry, A. M. Richards, M. E. Forster et al., Cardiovascular effects of native and non-native urotensin II and urotensin II-related peptide on rat and salmon hearts, Peptides, vol.27, pp.3261-3268, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01973954

C. D. Proulx, B. J. Holleran, A. A. Boucard, E. Escher, G. Guillemette et al., Mutational analysis of the conserved Asp2.50 and ERY motif reveals signaling bias of the urotensin II receptor, Mol. Pharmacol, vol.74, pp.552-561, 2008.

C. D. Proulx, B. J. Holleran, P. Lavigne, E. Escher, G. Guillemette et al., Biological properties and functional determinants of the urotensin II receptor, Peptides, vol.29, pp.691-699, 2008.

C. D. Proulx, M. Simaan, E. Escher, S. A. Laporte, G. Guillemette et al., Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization, Biochem. J, vol.385, p.115, 2005.

D. Provost, A. Cantagrel, P. Lebailly, A. Jaffré, V. Loyant et al., Brain tumours and exposure to pesticides: a case-control study in southwestern France, Occup. Environ. Med, vol.64, pp.509-514, 2007.

P. Pu, C. Kang, J. Li, and H. Jiang, Antisense and dominant-negative AKT2 cDNA inhibits glioma cell invasion, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.25, pp.172-178, 2004.

J. Qi, J. Du, X. Tang, J. Li, B. Wei et al., The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting, Heart Vessels, vol.19, pp.81-88, 2004.

J. Qi, L. K. Minor, C. Smith, B. Hu, J. Yang et al., Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors, Peptides, vol.26, pp.683-690, 2005.

J. Qi, R. Schulingkamp, T. J. Parry, R. Colburn, D. Stone et al., Urotensin-II induces ear flushing in rats, Br. J. Pharmacol, vol.150, pp.415-423, 2007.

F. B. Quan, M. Bougerol, F. Rigour, N. B. Kenigfest, and H. Tostivint, Characterization of the true ortholog of the urotensin II-related peptide (URP) gene in teleosts, Gen. Comp. Endocrinol, vol.177, pp.205-212, 2012.

Q. Quick and O. Skalli, Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells, Exp. Cell Res, vol.316, pp.1137-1147, 2010.

K. Radhakrishnan, B. Mokri, J. E. Parisi, W. M. O'fallon, J. Sunku et al., The trends in incidence of primary brain tumors in the population of, Ann. Neurol, vol.37, pp.67-73, 1995.

E. Rakowski, G. S. Hassan, D. Dhanak, E. H. Ohlstein, S. A. Douglas et al., A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker, J. Mol. Cell. Cardiol, vol.39, pp.785-791, 2005.

S. M. Ranuncolo, V. Ladeda, S. Specterman, M. Varela, J. Lastiri et al., CD44 expression in human gliomas, J. Surg. Oncol, vol.79, pp.35-36, 2002.

B. Ratnikov, C. Ptak, J. Han, J. Shabanowitz, D. F. Hunt et al., Talin phosphorylation sites mapped by mass spectrometry, J. Cell Sci, vol.118, pp.4921-4923, 2005.

D. A. Reardon, G. Akabani, R. E. Coleman, A. H. Friedman, H. S. Friedman et al., Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.20, pp.1389-1397, 2002.

D. A. Reardon, J. J. Vredenburgh, A. Desjardins, K. B. Peters, S. Sathornsumetee et al., Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma, J. Neurooncol, vol.108, pp.499-506, 2012.

J. H. Rees, Diagnosis and treatment in neuro-oncology: an oncological perspective, Br. J. Radiol, vol.84, pp.82-89, 2012.

K. Reif and J. G. Cyster, RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines, J. Immunol. Baltim. Md, vol.164, pp.4720-4729, 1950.

G. Ren and M. S. Crampton, Cortactin: Coordinating adhesion and the actin cytoskeleton at cellular protrusions, Cell Motil. Cytoskeleton, vol.66, pp.865-873, 2009.

M. H. Repacholi, Health risks from the use of mobile phones, Toxicol. Lett, vol.120, pp.323-331, 2001.

M. Rey, M. Vicente-manzanares, F. Viedma, M. Yáñez-mó, A. Urzainqui et al., Cutting edge: association of the motor protein nonmuscle myosin heavy chain-IIA with the C terminus of the chemokine receptor CXCR4 in T lymphocytes, J. Immunol. Baltim. Md, vol.169, pp.5410-5414, 1950.

A. M. Richards, M. G. Nicholls, J. G. Lainchbury, S. Fisher, Y. et al., Plasma urotensin II in heart failure, Lancet, vol.360, pp.545-546, 2002.

D. S. Rickman, M. P. Bobek, D. E. Misek, R. Kuick, M. Blaivas et al., Distinctive Molecular Profiles of High-Grade and Low-Grade Gliomas Based on Oligonucleotide Microarray Analysis, Cancer Res, vol.61, pp.6885-6891, 2001.

J. L. Ridet, A. Privat, S. K. Malhotra, and F. H. Gage, Reactive astrocytes: cellular and molecular cues to biological function, Trends Neurosci, vol.20, pp.570-577, 1997.

A. J. Ridley, Rho GTPases and cell migration, J. Cell Sci, vol.114, pp.2713-2722, 2001.

A. J. Ridley, Cell Migration: Integrating Signals from Front to Back, Science, vol.302, pp.1704-1709, 2003.

A. J. Ridley, Life at the Leading Edge, Cell, vol.145, pp.1012-1022, 2011.

A. J. Ridley and A. Hall, The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors, Cell, vol.70, pp.389-399, 1992.

S. L. Ritter and R. A. Hall, Fine-tuning of GPCR activity by receptor-interacting proteins, Nat. Rev. Mol. Cell Biol, vol.10, pp.819-830, 2009.

R. J. Rivas, R. S. Nishioka, and H. A. Bern, In vitro effects of somatostatin and urotensin II on prolactin and growth hormone secretion in tilapia, Oreochromis mossambicus, Gen. Comp. Endocrinol, vol.63, pp.245-251, 1986.

A. M. Robertson, C. C. Bird, A. W. Waddell, and A. R. Currie, Morphological aspects of glucocorticoid-induced cell death in human lymphoblastoid cells, J. Pathol, vol.126, pp.181-187, 1978.

J. M. Rodríguez-frade, A. J. Vila-coro, A. M. De-ana, J. P. Albar, C. Martínez-a et al., The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2, Proc. Natl. Acad. Sci. U. S. A, vol.96, pp.3628-3633, 1999.

E. V. Romanova, K. Sasaki, V. Alexeeva, F. S. Vilim, J. Jing et al., Urotensin II in Invertebrates: From Structure to Function in Aplysia californica. Plos One, p.7, 2012.

S. Rosell, E. Burcher, D. Chang, and K. Folkers, Cardiovascular and metabolic actions of neurotensin and (Gln4)-Neurotensin, Acta Physiol. Scand, vol.98, pp.484-491, 1976.

B. Ross, K. Mckendy, and A. Giaid, Role of urotensin II in health and disease, Am. J. Physiol. -Regul. Integr. Comp. Physiol, vol.298, pp.1156-1172, 2010.

K. L. Rossman, C. J. Der, and J. Sondek, GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors, Nat. Rev. Mol. Cell Biol, vol.6, pp.167-180, 2005.

W. J. Rossowski, B. Cheng, J. E. Taylor, R. Datta, and D. H. Coy, Human urotensin IIinduced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists, Eur. J. Pharmacol, vol.438, pp.159-170, 2002.

G. E. Rovati, V. Capra, and R. R. Neubig, The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State, Mol. Pharmacol, vol.71, pp.959-964, 2007.

R. Roy, B. Zhang, and M. A. Moses, Making the cut: Protease-mediated regulation of angiogenesis, Exp. Cell Res, vol.312, pp.608-622, 2006.

T. Rozario and D. W. Desimone, The extracellular matrix in development and morphogenesis: a dynamic view, Dev. Biol, vol.341, pp.126-140, 2010.

A. M. Ruder, M. A. Waters, M. A. Butler, T. Carreón, G. M. Calvert et al., Gliomas and farm pesticide exposure in men: the upper midwest health study, Arch. Environ. Health, vol.59, pp.650-657, 2004.

E. Ruoslahti and E. Engvall, Complexing of fibronectin glycosaminoglycans and collagen, Biochim. Biophys. Acta, vol.631, pp.350-358, 1980.

E. Ruoslahti and M. D. Pierschbacher, New perspectives in cell adhesion: RGD and integrins, Science, vol.238, pp.491-497, 1987.

F. D. Russell, P. Kearns, I. Toth, and P. Molenaar, Urotensin-II-converting enzyme activity of furin and trypsin in human cells in vitro, J. Pharmacol. Exp. Ther, vol.310, pp.209-214, 2004.

F. D. Russell, D. Meyers, A. J. Galbraith, N. Bett, I. Toth et al., Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure, Am. J. Physiol. Heart Circ. Physiol, vol.285, pp.1576-1581, 2003.

F. D. Russell and P. Molenaar, Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart, Cardiovasc. Res, vol.63, pp.673-681, 2004.

F. D. Russell, P. Molenaar, and D. M. Brien, Cardiostimulant effects of urotensin-II in human heart in vitro, Br. J. Pharmacol, vol.132, pp.5-9, 2001.

J. T. Rutka, S. Ivanchuk, S. Mondal, M. Taylor, K. Sakai et al., Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells, Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci, vol.17, pp.503-515, 1999.

M. E. Sáez, T. Smani, R. Ramírez-lorca, I. Díaz, M. Serrano-ríos et al., Association analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistance, Plos One, vol.6, p.19327, 2011.

E. Sahai and C. J. Marshall, Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis, Nat. Cell Biol, vol.5, pp.711-719, 2003.

Y. Saitoh, J. Kuratsu, H. Takeshima, S. Yamamoto, and Y. Ushio, Expression of osteopontin in human glioma. Its correlation with the malignancy, Lab. Investig. J. Tech. Methods Pathol, vol.72, pp.55-63, 1995.

M. Sakurai-yageta, C. Recchi, G. L. Dez, J. Sibarita, L. Daviet et al., The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA, J. Cell Biol, vol.181, pp.985-998, 2008.

R. Salgia, B. Brunkhorst, E. Pisick, J. L. Li, S. H. Lo et al., Increased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR/ABL, Oncogene, vol.11, pp.1149-1155, 1995.

M. Salvati, E. Caroli, G. Rocchi, A. Frati, C. Brogna et al., Post-traumatic glioma. Report of four cases and review of the literature, Tumori, vol.90, pp.416-419, 2004.

N. Sanai and M. S. Berger, Glioma extent of resection and its impact on patient outcome, Neurosurgery, vol.62, pp.753-764, 2008.

M. Sandström, M. Johansson, J. Sandström, A. T. Bergenheim, and R. Henriksson, Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression, Int. J. Dev. Neurosci. Off. J. Int. Soc. Dev. Neurosci, vol.17, pp.473-481, 1999.

I. Sansal and W. R. Sellers, The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway, J. Clin. Oncol, vol.22, pp.2954-2963, 2004.

V. Sapountzi, I. R. Logan, and C. N. Robson, Cellular functions of TIP60, Int. J. Biochem. Cell Biol, vol.38, pp.1496-1509, 2006.

H. Sasaki, K. Yoshida, E. Ikeda, H. Asou, M. Inaba et al., Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy, Cancer, vol.82, pp.1921-1931, 1998.

R. M. Saunders, M. R. Holt, L. Jennings, D. H. Sutton, I. L. Barsukov et al., Role of vinculin in regulating focal adhesion turnover, Eur. J. Cell Biol, vol.85, pp.487-500, 2006.

V. Sauzeau, E. Le-mellionnec, J. Bertoglio, E. Scalbert, P. Pacaud et al., Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase, Circ. Res, vol.88, pp.1102-1104, 2001.

M. Schilling, M. Besselmann, C. Leonhard, M. Mueller, E. B. Ringelstein et al., Microglial activation precedes and predominates over macrophage infiltration in transient focal cerebral ischemia: a study in green fluorescent protein transgenic bone marrow chimeric mice, Exp. Neurol, vol.183, pp.25-33, 2003.

T. Schioppa, B. Uranchimeg, A. Saccani, S. K. Biswas, A. Doni et al., Regulation of the Chemokine Receptor CXCR4 by Hypoxia, J. Exp. Med, vol.198, pp.1391-1402, 2003.

A. Schirenbeck, T. Bretschneider, R. Arasada, M. Schleicher, and J. Faix, The Diaphanousrelated formin dDia2 is required for the formation and maintenance of filopodia, Nat. Cell Biol, vol.7, pp.619-625, 2005.

J. Schlessinger, Cell signaling by receptor tyrosine kinases, Cell, vol.103, pp.211-225, 2000.

H. Schlüter, J. Jankowski, J. Rykl, J. Thiemann, S. Belgardt et al., Detection of protease activities with the mass-spectrometry-assisted enzyme-screening (MES) system, Anal. Bioanal. Chem, vol.377, pp.1102-1107, 2003.

O. Schnell, B. Krebs, E. Wagner, A. Romagna, A. J. Beer et al., Expression of Integrin ?v?3 in Gliomas Correlates with Tumor Grade and Is not Restricted to Tumor Vasculature, Brain Pathol. Zurich Switz, vol.18, pp.378-386, 2008.

M. Schoumacher, R. D. Goldman, D. Louvard, and D. M. Vignjevic, Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia, J. Cell Biol, vol.189, pp.541-556, 2010.

M. G. Scott, V. Pierotti, H. Storez, E. Lindberg, A. Thuret et al., Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins, Mol. Cell. Biol, vol.26, pp.3432-3445, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00069767

R. W. Scott and M. F. Olson, LIM kinases: function, regulation and association with human disease, J. Mol. Med. Berl. Ger, vol.85, pp.555-568, 2007.

T. Seck, R. Baron, and W. C. Horne, Binding of Filamin to the C-terminal Tail of the Calcitonin Receptor Controls Recycling, J. Biol. Chem, vol.278, pp.10408-10416, 2003.

J. Segain, M. Rolli-derkinderen, N. Gervois, D. Raingeard-de-la-blétière, G. Loirand et al., Urotensin II is a new chemotactic factor for UT receptor-expressing monocytes, J. Immunol. Baltim. Md, vol.179, pp.901-909, 1950.

A. Sehgal, C. Keener, A. L. Boynton, J. Warrick, and G. P. Murphy, CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells, J. Surg. Oncol, vol.69, pp.99-104, 1998.

M. A. Sells, J. T. Boyd, and J. Chernoff, -activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts, J. Cell Biol, vol.145, pp.837-849, 1999.

G. L. Semenza, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, vol.3, pp.721-732, 2003.

G. Servant, O. D. Weiner, P. Herzmark, T. Balla, J. W. Sedat et al., Polarization of chemoattractant receptor signaling during neutrophil chemotaxis, Science, vol.287, pp.1037-1040, 2000.

B. H. Shah and K. J. Catt, GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences, Trends Neurosci, vol.27, pp.48-53, 2004.

H. Sheng, J. Shao, M. K. Washington, and R. N. Dubois, Prostaglandin E2 increases growth and motility of colorectal carcinoma cells, J. Biol. Chem, vol.276, pp.18075-18081, 2001.

A. Shenouda, S. A. Douglas, E. H. Ohlstein, and A. Giaid, Localization of Urotensin-II Immunoreactivity in Normal Human Kidneys and Renal Carcinoma, J. Histochem. Cytochem, vol.50, pp.885-889, 2002.

N. Shinojima, K. Tada, S. Shiraishi, T. Kamiryo, M. Kochi et al., Prognostic Value of Epidermal Growth Factor Receptor in Patients with Glioblastoma Multiforme, Cancer Res, vol.63, pp.6962-6970, 2003.

H. Shiraha, A. Glading, J. Chou, Z. Jia, and A. Wells, Activation of m-Calpain (Calpain II) by Epidermal Growth Factor Is Limited by Protein Kinase A Phosphorylation of m-Calpain, Mol. Cell. Biol, vol.22, pp.2716-2727, 2002.

Y. Shiraishi, T. Watanabe, T. Suguro, M. Nagashima, R. Kato et al., Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice, J. Hypertens, vol.26, pp.1955-1965, 2008.

H. S. Shpetner and R. B. Vallee, Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules, Cell, vol.59, pp.421-432, 1989.

D. Shweiki, A. Itin, D. Soffer, and E. Keshet, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, vol.359, pp.843-845, 1992.

H. Sibony-benyamini and H. Gil-henn, Invadopodia: The leading force, Eur. J. Cell Biol, 2012.

P. N. Sidharta, K. Rave, L. Heinemann, E. Chiossi, S. Krähenbühl et al., Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus, Br. J. Clin. Pharmacol, vol.68, pp.502-510, 2009.

P. N. Sidharta, F. D. Wagner, H. Bohnemeier, A. Jungnik, A. Halabi et al., Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients, Clin. Pharmacol. Ther, vol.80, pp.246-256, 2006.

P. N. Sidharta, F. D. Wagner, H. Bohnemeier, A. Jungnik, A. Halabi et al., Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients, Clin. Pharmacol. Ther, vol.80, pp.246-256, 2006.

R. A. Silvestre, E. M. Egido, R. Hernández, J. Leprince, D. Chatenet et al., Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas, Eur. J. Endocrinol. Eur. Fed. Endocr. Soc, vol.151, pp.803-809, 2004.
URL : https://hal.archives-ouvertes.fr/hal-01974193

R. A. Silvestre, E. M. Egido, R. Hernández, M. , and J. , Characterization of the insulinostatic effect of urotensin II: a study in the perfused rat pancreas, Regul. Pept, vol.153, pp.37-42, 2009.

R. A. Silvestre, J. Rodríguez-gallardo, E. M. Egido, M. , and J. , Inhibition of insulin release by urotensin II--a study on the perfused rat pancreas, Horm. Metab. Res. Horm.-Stoffwechselforschung Horm. Métabolisme, vol.33, pp.379-381, 2001.

M. I. Simon, M. P. Strathmann, and N. Gautam, Diversity of G proteins in signal transduction, Science, vol.252, pp.802-808, 1991.

J. S. Smith, I. Tachibana, S. M. Passe, B. K. Huntley, T. J. Borell et al., PTEN Mutation, EGFR Amplification, and Outcome in Patients With Anaplastic Astrocytoma and Glioblastoma Multiforme, J. Natl. Cancer Inst, vol.93, pp.1246-1256, 2001.

M. C. Smith, K. E. Luker, J. R. Garbow, J. L. Prior, E. Jackson et al., CXCR4 regulates growth of both primary and metastatic breast cancer, Cancer Res, vol.64, pp.8604-8612, 2004.

D. Sohy, H. Yano, P. Nadai, . De, E. Urizar et al., Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of "Selective, Antagonists. J. Biol. Chem, vol.284, pp.31270-31279, 2009.

H. Y. Song, M. J. Lee, M. Y. Kim, K. H. Kim, I. H. Lee et al., Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis, Biochim. Biophys. Acta Bba -Mol. Cell Biol. Lipids, vol.1801, pp.23-30, 2010.

N. Song, W. Ding, S. Chu, J. Zhao, X. Dong et al., Urotensin II stimulates vascular endothelial growth factor secretion from adventitial fibroblasts in synergy with angiotensin II, Circ. J. Off. J. Jpn. Circ. Soc, vol.76, pp.1267-1273, 2012.

W. Song, A. E. Abdel-razik, W. Lu, Z. Ao, D. G. Johns et al., Urotensin II and renal function in the rat, Kidney Int, vol.69, pp.1360-1368, 2006.

W. Song, J. Mcdonald, V. Camarda, G. Calo, R. Guerrini et al., Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity, Naunyn. Schmiedebergs Arch. Pharmacol, vol.373, pp.148-157, 2006.

Y. Sotsios, G. C. Whittaker, J. Westwick, and S. G. Ward, The CXC chemokine stromal cellderived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes, J. Immunol. Baltim. Md, vol.163, pp.5954-5963, 1950.

S. Spiegel and S. Milstien, Sphingosine-1-phosphate: an enigmatic signalling lipid, Nat. Rev. Mol. Cell Biol, vol.4, pp.397-407, 2003.

R. Spinazzi, G. Albertin, B. Nico, D. Guidolin, R. Di-liddo et al., Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro, Int. J. Mol. Med, vol.18, pp.1107-1112, 2006.

R. Spinazzi, G. Albertin, B. Nico, D. Guidolin, R. Di-liddo et al., Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro, Int. J. Mol. Med, vol.18, pp.1107-1112, 2006.

S. Srinivasan, F. Wang, S. Glavas, A. Ott, F. Hofmann et al., Rac and Cdc42 play distinct roles in regulating PI(3,4,5)P3 and polarity during neutrophil chemotaxis, J. Cell Biol, vol.160, pp.375-385, 2003.

M. Stahlhut and B. Van-deurs, Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton, Mol. Biol. Cell, vol.11, pp.325-337, 2000.

J. D. Stiles, P. T. Ostrow, L. L. Balos, S. J. Greenberg, R. Plunkett et al., Jr (1997) Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas, J. Neuropathol. Exp. Neurol, vol.56, pp.435-439

A. Stirrat, M. Gallagher, S. A. Douglas, E. H. Ohlstein, C. Berry et al., Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries, Am. J. Physiol. Heart Circ. Physiol, vol.280, pp.925-928, 2001.

A. Stratmann, W. Risau, and K. H. Plate, Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma Angiogenesis, Am. J. Pathol, vol.153, pp.1459-1466, 1998.

R. Stupp, M. E. Hegi, B. Neyns, R. Goldbrunner, U. Schlegel et al., Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, pp.2712-2718, 2010.

R. Stupp, N. Pavlidis, J. , and S. , ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. Esmo, vol.16, issue.1, pp.64-65, 2005.

Y. Sue, C. Chen, Y. Hsu, C. Hou, C. Cheng et al., Urotensin II induces transactivation of the epidermal growth factor receptor via transient oxidation of SHP-2 in the rat renal tubular cell line NRK-52E, Growth Factors Chur Switz, vol.27, pp.155-162, 2009.

T. Sugo and M. Mori, Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain, Peptides, vol.29, pp.809-812, 2008.

T. Sugo, Y. Murakami, Y. Shimomura, M. Harada, M. Abe et al., Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain, Biochem. Biophys. Res. Commun, vol.310, pp.860-868, 2003.

T. Suguro, T. Watanabe, Y. Ban, S. Kodate, A. Misaki et al., Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension, Am. J. Hypertens, vol.20, pp.211-217, 2007.

T. Suguro, T. Watanabe, S. Kodate, G. Xu, T. Hirano et al., Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes, Clin. Sci. Lond. Engl, vol.115, pp.327-334, 1979.

Y. Sun, Z. Cheng, L. Ma, P. , and G. , Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation, J. Biol. Chem, vol.277, pp.49212-49219, 2002.

A. Suzuki, T. Kaisho, M. Ohishi, M. Tsukio-yamaguchi, T. Tsubata et al., Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination, J. Exp. Med, vol.197, pp.657-667, 2003.

M. Suzuki, M. Suzuki, J. Nakayama, A. Suzuki, K. Angata et al., Polysialic acid facilitates tumor invasion by glioma cells, Glycobiology, vol.15, pp.887-894, 2005.

S. Suzuki, Z. Wenyi, M. Hirai, Y. Hinokio, C. Suzuki et al., Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese, Peptides, vol.25, pp.1803-1808, 2004.

A. Suzumura, M. Sawada, and T. Marunouchi, Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor, Brain Res, vol.713, pp.192-198, 1996.

M. Sverdlov, V. Shinin, A. T. Place, M. Castellon, and R. D. Minshall, Filamin A regulates caveolae internalization and trafficking in endothelial cells, Mol. Biol. Cell, vol.20, pp.4531-4540, 2009.

T. M. Svitkina, E. A. Bulanova, O. Y. Chaga, D. M. Vignjevic, S. Kojima et al., Mechanism of filopodia initiation by reorganization of a dendritic network, J. Cell Biol, vol.160, pp.409-421, 2003.

T. M. Svitkina, A. B. Verkhovsky, K. M. Mcquade, and G. G. Borisy, Analysis of the actinmyosin II system in fish epidermal keratocytes: mechanism of cell body translocation, J. Cell Biol, vol.139, pp.397-415, 1997.

A. M. Tadeu, S. Ribeiro, J. Johnston, I. Goldberg, D. Gerloff et al., CENP-V is required for centromere organization, chromosome alignment and cytokinesis, Embo J, vol.27, pp.2510-2522, 2008.

S. Tadokoro, S. J. Shattil, K. Eto, V. Tai, R. C. Liddington et al., Talin Binding to Integrin ß Tails: A Final Common Step in Integrin Activation, Science, vol.302, pp.103-106, 2003.

R. S. Taichman, C. Cooper, E. T. Keller, K. J. Pienta, N. S. Taichman et al., Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone, Cancer Res, vol.62, pp.1832-1837, 2002.

J. A. Takahashi, H. Mori, M. Fukumoto, K. Igarashi, M. Jaye et al., Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues, Proc. Natl. Acad. Sci. U. S. A, vol.87, pp.5710-5714, 1990.

K. Takahashi, K. Totsune, O. Murakami, Z. Arihara, T. Noshiro et al., Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II, Peptides, vol.24, pp.301-306, 2003.

K. Takahashi, K. Totsune, O. Murakami, and S. Shibahara, Expression of urotensin II and urotensin II receptor mRNAs in various human tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells, Peptides, vol.22, pp.1175-1179, 2001.

Y. Takai, T. Sasaki, and T. Matozaki, Small GTP-Binding Proteins, Physiol. Rev, vol.81, pp.153-208, 2001.

S. Takashima, N. Sugimoto, N. Takuwa, Y. Okamoto, K. Yoshioka et al., G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase, Cardiovasc. Res, vol.79, pp.689-697, 2008.

M. Tal, D. A. Ammar, M. Karpuj, V. Krizhanovsky, M. Naim et al., A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia, Biochem. Biophys. Res. Commun, vol.209, pp.752-759, 1995.

B. R. Tambuyzer, P. Ponsaerts, and E. J. Nouwen, Microglia: gatekeepers of central nervous system immunology, J. Leukoc. Biol, vol.85, pp.352-370, 2009.

W. Tan, D. Martin, and J. S. Gutkind, The Galpha13-Rho signaling axis is required for SDF-1-induced migration through CXCR4, J. Biol. Chem, vol.281, pp.39542-39549, 2006.

T. Tanaka, Y. Manome, P. Wen, D. W. Kufe, and H. A. Fine, Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth, Nat. Med, vol.3, pp.437-442, 1997.

G. Tarone, D. Cirillo, F. G. Giancotti, P. M. Comoglio, and P. C. Marchisio, Rous sarcoma virus-transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes, Exp. Cell Res, vol.159, pp.141-157, 1985.

T. K. Tarrant, R. R. Rampersad, D. Esserman, L. R. Rothlein, P. Liu et al., Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN), Clin. Immunol. Orlando Fla, vol.129, pp.115-122, 2008.

K. Tasaki, M. Hori, H. Ozaki, H. Karaki, and I. Wakabayashi, Mechanism of human urotensin II-induced contraction in rat aorta, J. Pharmacol. Sci, vol.94, pp.376-383, 2004.

M. C. Tate and M. K. Aghi, Biology of angiogenesis and invasion in glioma, Neurother. J. Am. Soc. Exp. Neurother, vol.6, pp.447-457, 2009.

R. Tavano, R. L. Contento, S. J. Baranda, M. Soligo, L. Tuosto et al., CD28 interaction with filamin-A controls lipid raft accumulation at the T-cell immunological synapse, Nat. Cell Biol, vol.8, pp.1270-1276, 2006.

D. R. Terfera, M. C. Brown, and C. E. Turner, Epidermal growth factor stimulates serine/threonine phosphorylation of the focal adhesion protein paxillin in a MEK-dependent manner in normal rat kidney cells, J. Cell. Physiol, vol.191, pp.82-94, 2002.

W. R. Thelin, Y. Chen, M. Gentzsch, S. M. Kreda, J. L. Sallee et al., Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR, J. Clin. Invest, vol.117, pp.364-374, 2007.

S. Thieme, T. Gyárfás, C. Richter, G. Ozhan, J. Fu et al., The histone demethylase UTX regulates stem cell migration and hematopoiesis, Blood, vol.121, pp.2462-2473, 2013.

J. P. Thompson, P. Watt, S. Sanghavi, J. W. Strupish, and D. G. Lambert, A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study, Anesth. Analg, vol.97, pp.1501-1503, 2003.

L. Tian, C. Li, J. Qi, P. Fu, X. Yu et al., Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-?1-mediated renal fibrosis and dysfunction, Am. J. Physiol. -Endocrinol. Metab, vol.295, pp.1234-1242, 2008.

A. V. Timoshenko, G. Xu, S. Chakrabarti, P. K. Lala, and C. Chakraborty, Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells, Exp. Cell Res, vol.289, pp.265-274, 2003.

T. Tokumitsu and K. Maramorosch, Cytoplasmic protrusions in insect cells during mitosis in vitro, J. Cell Biol, vol.34, pp.677-683, 1967.

K. F. Tolias, L. C. Cantley, and C. L. Carpenter, Rho family GTPases bind to phosphoinositide kinases, J. Biol. Chem, vol.270, pp.17656-17659, 1995.

H. Tostivint, L. Joly, I. Lihrmann, C. Parmentier, A. Lebon et al., Comparative genomics provides evidence for close evolutionary relationships between the urotensin II and somatostatin gene families, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.2237-2242, 2006.

H. Tostivint, F. B. Quan, M. Bougerol, N. B. Kenigfest, and I. Lihrmann, Impact of gene/genome duplications on the evolution of the urotensin II and somatostatin families, Gen. Comp. Endocrinol, 2013.

K. Totsune, K. Takahashi, Z. Arihara, M. Sone, S. Ito et al., Increased plasma urotensin II levels in patients with diabetes mellitus, Clin. Sci. Lond. Engl, vol.104, pp.1-5, 1979.

K. Totsune, K. Takahashi, Z. Arihara, M. Sone, O. Murakami et al., Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy, Peptides, vol.25, pp.1809-1814, 2004.

K. Totsune, K. Takahashi, Z. Arihara, M. Sone, F. Satoh et al., Role of urotensin II in patients on dialysis, Lancet, vol.358, pp.810-811, 2001.

J. Trebicka, L. Leifeld, M. Hennenberg, E. Biecker, A. Eckhardt et al., Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats, Hepatol. Baltim. Md, vol.47, pp.1264-1276, 2008.

F. Trettel, S. Di-bartolomeo, C. Lauro, M. Catalano, M. T. Ciotti et al., Ligandindependent CXCR2 dimerization, J. Biol. Chem, vol.278, pp.40980-40988, 2003.

C. Tsai, S. Loh, J. Liu, J. Lin, Y. Chen et al., Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells, Atherosclerosis, vol.206, pp.86-94, 2009.

W. Tsai, A. D. Morielli, and E. G. Peralta, The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity, Embo J, vol.16, pp.4597-4605, 1997.

C. E. Turner, Paxillin interactions. J. Cell Sci, vol.113, pp.4139-4140, 2000.

P. Turowski, T. Myles, B. A. Hemmings, A. Fernandez, and N. J. Lamb, Vimentin dephosphorylation by protein phosphatase 2A is modulated by the targeting subunit B55, Mol. Biol. Cell, vol.10, 1997.

A. Tzanidis, R. D. Hannan, W. G. Thomas, D. Onan, D. J. Autelitano et al., Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy, Circ. Res, vol.93, pp.246-253, 2003.

A. Ullrich and J. Schlessinger, Signal transduction by receptors with tyrosine kinase activity, Cell, vol.61, pp.203-212, 1990.

N. Unoki, T. Murakami, K. Nishijima, K. Ogino, N. Rooijen et al., , p.SDF, 2010.

, /CXCR4 Contributes to the Activation of Tip Cells and Microglia in Retinal Angiogenesis, Invest. Ophthalmol. Vis. Sci, vol.51, pp.3362-3371

J. Van-rheenen, J. Condeelis, and M. Glogauer, A common cofilin activity cycle in invasive tumor cells and inflammatory cells, J. Cell Sci, vol.122, pp.305-311, 2009.

R. B. Vaughan and J. P. Trinkaus, Movements of epithelial cell sheets in vitro, J. Cell Sci, vol.1, pp.407-413, 1966.

J. B. Ventimiglia, C. J. Wikstrand, L. E. Ostrowski, M. A. Bourdon, V. A. Lightner et al., Tenascin expression in human glioma cell lines and normal tissues, J. Neuroimmunol, vol.36, pp.41-55, 1992.

B. S. Verbeek, S. S. Adriaansen-slot, T. M. Vroom, T. Beckers, and G. Rijksen, Overexpression of EGFR and c-erbB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts, Febs Lett, vol.425, pp.145-150, 1998.

R. Vergura, V. Camarda, A. Rizzi, M. Spagnol, R. Guerrini et al., Urotensin II stimulates plasma extravasation in mice via UT receptor activation, Naunyn. Schmiedebergs Arch. Pharmacol, vol.370, pp.347-352, 2004.

R. G. Verhaak, K. A. Hoadley, E. Purdom, V. Wang, Y. Qi et al., Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, vol.17, pp.98-110, 2010.

V. V. Verkhusha, S. Tsukita, O. , and H. , Actin dynamics in lamellipodia of migrating border cells in the Drosophila ovary revealed by a GFP-actin fusion protein, Febs Lett, vol.445, pp.395-401, 1999.

A. P. Vicari and C. Caux, Chemokines in cancer, Cytokine Growth Factor Rev, vol.13, pp.143-154, 2002.

M. Vicente-manzanares, X. Ma, R. S. Adelstein, and A. R. Horwitz, Non-muscle myosin II takes centre stage in cell adhesion and migration, Nat. Rev. Mol. Cell Biol, vol.10, pp.778-790, 2009.

P. Vitorino and T. Meyer, Modular control of endothelial sheet migration, Genes Dev, vol.22, pp.3268-3281, 2008.

L. Vogt, C. Chiurchiu, H. Chadha-boreham, P. Danaietash, J. Dingemanse et al., Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy, Hypertension, vol.55, pp.1206-1209, 2010.

O. V. Volpert, T. Fong, A. E. Koch, J. D. Peterson, C. Waltenbaugh et al., Inhibition of Angiogenesis by Interleukin 4, J. Exp. Med, vol.188, pp.1039-1046, 1998.

V. Bülow, C. Hayen, W. Hartmann, A. Mueller-klieser, W. Allolio et al., Endothelial capillaries chemotactically attract tumour cells, J. Pathol, vol.193, pp.367-376, 2001.

V. Wichert, G. Haimovich, B. Feng, G. Sheetz, and M. P. , Force-dependent integrincytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2, Embo J, vol.22, pp.5023-5035, 2003.

A. Vroon, C. J. Heijnen, M. S. Lombardi, P. M. Cobelens, F. Mayor et al., Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4, J. Leukoc. Biol, vol.75, pp.901-909, 2004.

A. Vroon, C. J. Heijnen, R. Raatgever, I. P. Touw, R. E. Ploemacher et al., GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo, J. Leukoc. Biol, vol.75, pp.698-704, 2004.

H. Wang, K. Dong, X. Xue, P. Feng, W. et al., Elevated expression of urotensin II and its receptor in diethylnitrosamine-mediated precancerous lesions in rat liver, Peptides, vol.32, pp.382-387, 2011.

H. X. Wang, X. J. Zeng, Y. Liu, J. Wang, L. Q. Lu et al., Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse, Regul. Pept, vol.154, pp.85-90, 2009.

J. Wang, L. He, C. A. Combs, G. Roderiquez, and M. A. Norcross, Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions, Mol. Cancer Ther, vol.5, pp.2474-2483, 2006.

S. Wang, J. Hong, C. Hsueh, and C. Chiang, Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model, Lab. Investig. J. Tech. Methods Pathol, vol.92, pp.151-162, 2012.

Y. Wang, H. Cao, J. Chen, and M. A. Mcniven, A direct interaction between the large GTPase dynamin-2 and FAK regulates focal adhesion dynamics in response to active Src, Mol. Biol. Cell, vol.22, pp.1529-1538, 2011.

C. W. Ward, M. C. Lawrence, V. A. Streltsov, T. E. Adams, and N. M. Mckern, The insulin and EGF receptor structures: new insights into ligand-induced receptor activation, Trends Biochem. Sci, vol.32, pp.129-137, 2007.

T. Watanabe, R. Pakala, T. Katagiri, and C. R. Benedict, Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation, J. Hypertens, vol.19, pp.2191-2196, 2001.

T. Watanabe, T. Suguro, T. Kanome, Y. Sakamoto, S. Kodate et al., Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages, Hypertension, vol.46, pp.738-744, 2005.

T. Watanabe, S. Wang, J. Noritake, K. Sato, M. Fukata et al., Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration, Dev. Cell, vol.7, pp.871-883, 2004.

A. M. Watson, G. W. Lambert, K. J. Smith, and C. N. May, Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions, Hypertension, vol.42, pp.373-379, 2003.

A. M. Watson, M. Olukman, C. Koulis, Y. Tu, D. Samijono et al., Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes, Diabetologia, 2013.

D. Waugh and J. M. Conlon, Purification and characterization of urotensin II from the brain of a teleost (trout, Oncorhynchus mykiss) and an elasmobranch (skate, Raja rhina), Gen. Comp. Endocrinol, vol.92, pp.419-427, 1993.

D. Waugh, J. Youson, S. D. Mims, S. Sower, and J. M. Conlon, Urotensin II from the river lamprey (Lampetra fluviatilis), the sea lamprey (Petromyzon marinus), and the paddlefish (Polyodon spathula), Gen. Comp. Endocrinol, vol.99, pp.323-332, 1995.

D. J. Webb, J. T. Parsons, and A. F. Horwitz, Adhesion assembly, disassembly and turnover in migrating cells -over and over and over again, Nat. Cell Biol, vol.4, pp.97-100, 2002.

K. Wei, C. Huang, P. Chen, L. Feng, T. E. Wu et al., Evaluation of the Prognostic Value of CD44 in Glioblastoma Multiforme, Anticancer Res, vol.30, pp.253-259, 2010.

M. C. Weiger, S. Ahmed, E. S. Welf, and J. M. Haugh, Directional Persistence of Cell Migration Coincides with Stability of Asymmetric Intracellular Signaling, Biophys. J, vol.98, pp.67-75, 2010.

O. D. Weiner, Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass, Curr. Opin. Cell Biol, vol.14, pp.196-202, 2002.

M. D. Welch, A. Iwamatsu, and T. J. Mitchison, Actin polymerization is induced by Arp2/3 protein complex at the surface of Listeria monocytogenes, Nature, vol.385, pp.265-269, 1997.

M. D. Welch and R. D. Mullins, Cellular control of actin nucleation, Annu. Rev. Cell Dev. Biol, vol.18, pp.247-288, 2002.

I. B. Wilkinson, J. T. Affolter, S. L. De-haas, M. P. Pellegrini, J. Boyd et al., High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man, Cardiovasc. Res, vol.53, pp.341-347, 2002.

S. Wilson, G. Wilkinson, and G. Milligan, The CXCR1 and CXCR2 receptors form constitutive homo-and heterodimers selectively and with equal apparent affinities, J. Biol. Chem, vol.280, pp.28663-28674, 2005.

F. Winkler, Y. Kienast, M. Fuhrmann, L. Von-baumgarten, S. Burgold et al., Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis, Glia, vol.57, pp.1306-1315, 2009.

B. L. Wolfe and J. Trejo, Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis, Traffic Cph. Den, vol.8, pp.462-470, 2007.

A. Wolfman and I. G. Macara, A cytosolic protein catalyzes the release of GDP from p21ras, Science, vol.248, pp.67-69, 1990.

B. Wu, E. Y. Chien, C. D. Mol, G. Fenalti, W. Liu et al., Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists, Science, vol.330, pp.1066-1071, 2010.

Y. I. Wu, D. Frey, O. I. Lungu, A. Jaehrig, I. Schlichting et al., A genetically encoded photoactivatable Rac controls the motility of living cells, Nature, vol.461, pp.104-108, 2009.

Y. Wu, Z. Song, C. Zhou, S. Xing, D. Pei et al., Expression of urotensin II and its receptor in human lung adenocarcinoma A549 cells and the effect of urotensin II on lung adenocarcinoma growth in vitro and in vivo, Oncol. Rep, vol.24, pp.1179-1184, 2010.

K. Xiao, D. B. Mcclatchy, A. K. Shukla, Y. Zhao, M. Chen et al., Functional specialization of ?-arrestin interactions revealed by proteomic analysis, Proc. Natl. Acad. Sci, vol.104, pp.12011-12016, 2007.

Z. Xiao, N. Zhang, D. B. Murphy, and P. N. Devreotes, Dynamic distribution of chemoattractant receptors in living cells during chemotaxis and persistent stimulation, J. Cell Biol, vol.139, pp.365-374, 1997.

J. Xu, F. Wang, A. Van-keymeulen, P. Herzmark, A. Straight et al., Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils, Cell, vol.114, pp.201-214, 2003.

S. Xu, H. Jiang, B. Wu, J. Yang, C. et al., Urotensin II induces migration of endothelial progenitor cells via activation of the RhoA/Rho kinase pathway, Tohoku J. Exp. Med, vol.219, pp.283-288, 2009.

S. Xu, H. Wen, and H. Jiang, Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation, Mol. Med. Reports, vol.6, pp.197-200, 2012.

Y. Xu, T. A. Bismar, J. Su, B. Xu, G. Kristiansen et al., Filamin A regulates focal adhesion disassembly and suppresses breast cancer cell migration and invasion, J. Exp. Med, vol.207, pp.2421-2437, 2010.

Y. Yahata, Y. Shirakata, S. Tokumaru, L. Yang, X. Dai et al., A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation, J. Biol. Chem, vol.281, pp.13209-13216, 2006.

J. Yamauchi, Y. Miyamoto, H. Kokubu, H. Nishii, M. Okamoto et al., Endothelin suppresses cell migration via the JNK signaling pathway in a manner dependent upon Src kinase, Rac1, and Cdc42, Febs Lett, vol.527, pp.284-288, 2002.

H. Yanagisawa and E. C. Davis, Unraveling the mechanism of elastic fiber assembly: The roles of short fibulins, Int. J. Biochem. Cell Biol, vol.42, pp.1084-1093, 2010.

H. Yanagisawa, M. K. Schluterman, and R. A. Brekken, Fibulin-5, an integrin-binding matricellular protein: its function in development and disease, J. Cell Commun. Signal, vol.3, pp.337-347, 2009.

M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi et al., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, vol.332, pp.411-415, 1988.

C. Yang, L. Czech, S. Gerboth, S. Kojima, G. Scita et al., Novel roles of formin mDia2 in lamellipodia and filopodia formation in motile cells, Plos Biol, vol.5, p.317, 2007.

X. Yang, X. Man, S. Cai, Y. Yao, Z. Bu et al., Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects, Biochem. Biophys. Res. Commun, vol.349, pp.31-38, 2006.

Y. Yang, Y. Liu, X. Yao, Y. Ping, T. Jiang et al., Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1, Am. J. Pathol, vol.179, pp.1504-1512, 2011.

K. Yano, J. W. Hicks, H. Vaudry, and J. M. Conlon, Cardiovascular actions of frog urotensin II in the frog, Rana catesbeiana, Gen. Comp. Endocrinol, vol.97, pp.103-110, 1995.

K. Yi, M. Yu, L. Wu, and X. Tan, Effects of urotensin II on functional activity of late endothelial progenitor cells, Peptides, vol.33, pp.87-91, 2012.

C. M. Yoon, B. S. Hong, H. G. Moon, S. Lim, P. Suh et al., Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways, Blood, vol.112, pp.1129-1138, 2008.

H. Yu, T. Lin, and C. Tang, Bradykinin enhances cell migration in human prostate cancer cells through B2 receptor/PKC?/c-Src dependent signaling pathway. The Prostate, 2012.

J. Yu, A. Moon, and H. C. Kim, Both Platelet-Derived Growth Factor Receptor (PDGFR)-? and PDGFR-? Promote Murine Fibroblast Cell Migration, Biochem. Biophys. Res. Commun, vol.282, pp.697-700, 2001.

N. Yu, L. Erb, R. Shivaji, G. A. Weisman, and C. I. Seye, Binding of the P2Y2 nucleotide receptor to filamin A regulates migration of vascular smooth muscle cells, Circ. Res, vol.102, pp.581-588, 2008.

J. Yue, S. Huhn, and Z. Shen, Complex roles of filamin-A mediated cytoskeleton network in cancer progression, Cell Biosci, vol.3, p.7, 2013.

C. R. Yulis and K. Lederis, Extraurophyseal distribution of urotensin II immunoreactive neuronal perikarya and their processes, Proc. Natl. Acad. Sci. U. S. A, vol.83, pp.7079-7083, 1986.

G. Zadeh, K. Koushan, Q. Baoping, P. Shannon, and A. Guha, Role of Angiopoietin-2 in Regulating Growth and Vascularity of Astrocytomas, J. Oncol, pp.1-7, 2010.

D. Zagzag, R. Amirnovin, M. A. Greco, H. Yee, J. Holash et al., Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis, Lab. Investig. J. Tech. Methods Pathol, vol.80, pp.837-849, 2000.

D. Zagzag, D. R. Friedlander, D. C. Miller, J. Dosik, J. Cangiarella et al., Tenascin expression in astrocytomas correlates with angiogenesis, Cancer Res, vol.55, pp.907-914, 1995.

D. Zagzag, B. Shiff, G. I. Jallo, M. A. Greco, C. Blanco et al., Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase, Cancer Res, vol.62, pp.2660-2668, 2002.

D. Zagzag, H. Zhong, J. M. Scalzitti, E. Laughner, J. W. Simons et al., Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression, Cancer, vol.88, pp.2606-2618, 2000.

A. Zambonin-zallone, A. Teti, A. Carano, and P. C. Marchisio, The distribution of podosomes in osteoclasts cultured on bone laminae: effect of retinol, J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res, vol.3, pp.517-523, 1988.

E. Zamir, B. Z. Katz, S. Aota, K. M. Yamada, B. Geiger et al., Molecular diversity of cell-matrix adhesions, J. Cell Sci, vol.112, pp.1655-1669, 1999.

Z. Zeng, G. Liu, H. Li, X. Fan, D. Liu et al., The Effects of Urotensin-II on Proliferation of Pheochromocytoma Cells and mRNA Expression of Urotensin-II and Its Receptor in Pheochromocytoma Tissues, Ann. N. Y. Acad. Sci, vol.1073, pp.284-289, 2006.

A. Zerrouqi, B. Pyrzynska, M. Febbraio, D. J. Brat, and E. G. Van-meir, P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3, J. Clin. Invest, vol.122, pp.1283-1295, 2012.

P. Zetter and B. R. , Angiogenesis and Tumor Metastasis, Annu. Rev. Med, vol.49, pp.407-424, 1998.

H. Zhai, F. L. Heppner, and S. E. Tsirka, Microglia/Macrophages Promote Glioma Progression, Glia, vol.59, pp.472-485, 2011.

A. Y. Zhang, Y. Chen, D. X. Zhang, F. Yi, J. Qi et al., Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney, Am. J. Physiol. Renal Physiol, vol.285, pp.792-798, 2003.

M. Zhang and G. E. Breitwieser, High affinity interaction with filamin A protects against calcium-sensing receptor degradation, J. Biol. Chem, vol.280, pp.11140-11146, 2005.

T. Zhang and Y. Lu, The inhibitory effect of PEDF in glioma tumors, Aacr Meet. Abstr, p.709, 2005.

W. Zhang, Y. Liang, X. Wang, Y. Nie, L. Chong et al., Urotensin upregulates transforming growth factor-?1 expression of asthma airway through ERKdependent pathway, Mol. Cell. Biochem, vol.364, pp.291-298, 2012.

X. Zhang, Z. Fei, X. Bu, H. Zhen, Z. Zhang et al., Expression and significance of urokinase type plasminogen activator gene in human brain gliomas, J. Surg. Oncol, vol.74, pp.90-94, 2000.

Y. Zhang, Y. Li, R. Wei, Z. Wang, D. Bu et al., Urotensin II is an autocrine/paracrine growth factor for aortic adventitia of rat, Regul. Pept, vol.151, pp.88-94, 2008.

Y. Zhang, Z. Kuang, Y. Mao, R. Wei, S. Bao et al., Osteopontin is involved in urotensin II-induced migration of rat aortic adventitial fibroblasts, Peptides, vol.32, pp.2452-2458, 2011.

Y. Zhang, J. Li, Y. Li, and R. Wei, Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta, J. Hypertens, vol.26, pp.1119-1126, 2008.

Y. Zhang, Y. Li, B. Liu, R. Wei, D. Wang et al., Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol, Acta Pharmacol. Sin, vol.28, pp.36-43, 2007.

Z. Zhang and L. Li, TNFSF15 Modulates Neovascularization and Inflammation, Cancer Microenviron, vol.5, pp.237-247, 2012.

H. Zhao, S. Jin, and A. M. Gewirtz, The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemia, J. Biol. Chem, vol.287, pp.925-934, 2012.

Y. Zhao, C. E. Lyons, X. Jr, A. Templeton, D. J. Sang et al., Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion, Biochem. Biophys. Res. Commun, vol.369, pp.1215-1220, 2008.

X. Zheng, F. Jiang, M. Katakowski, Y. Lu, and M. Chopp, ADAM17 promotes glioma cell malignant phenotype, Mol. Carcinog, vol.51, pp.150-164, 2012.

Y. Zheng, Y. Xia, D. Hawke, M. Halle, M. L. Tremblay et al., FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST, Mol. Cell, vol.35, pp.11-25, 2009.

C. Zhou, Y. Wan, X. Chu, Z. Song, S. Xing et al., Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-?B pathway in tumor-bearing nude mice, Oncol. Lett, vol.4, pp.1259-1263, 2012.

Y. Zhou, P. H. Larsen, C. Hao, Y. , and V. W. , CXCR4 is a major chemokine receptor on glioma cells and mediates their survival, J. Biol. Chem, vol.277, pp.49481-49487, 2002.

Y. Z. Zhu, Z. J. Wang, Y. C. Zhu, L. Zhang, R. M. Oakley et al., Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a "vasoconstrictor" with a unique hemodynamic profile, Am. J. Physiol. Heart Circ. Physiol, vol.286, pp.830-836, 2004.

P. Ziltener, C. Mueller, B. Haenig, M. W. Scherz, and O. Nayler, Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines, J. Recept. Signal Transduct. Res, vol.22, pp.155-168, 2002.

C. Zoccali, F. Mallamaci, F. A. Benedetto, G. Tripepi, P. Pizzini et al., Urotensin II and cardiomyopathy in end-stage renal disease, Hypertension, vol.51, pp.326-333, 2008.

C. Zoccali, F. Mallamaci, G. Tripepi, S. Cutrupi, P. Pizzini et al., Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease, Kidney Int, vol.69, pp.1253-1258, 2006.

M. Zoudilova, P. Kumar, L. Ge, P. Wang, G. M. Bokoch et al., ) ?-Arrestindependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2, J. Biol. Chem, vol.282, pp.20634-20646, 2007.

M. Zoudilova, J. Min, H. L. Richards, D. Carter, T. Huang et al., ) ?-Arrestins Scaffold Cofilin with Chronophin to Direct Localized Actin Filament Severing and Membrane Protrusions Downstream of Protease-activated Receptor-2, J. Biol. Chem, vol.285, pp.14318-14329, 2010.

E. Zwick, H. Daub, N. Aoki, Y. Yamaguchi-aoki, I. Tinhofer et al., Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signaling, J. Biol. Chem, vol.272, pp.24767-24770, 1997.